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Abstract
William H. Gerwick
This thesis describes investigations of marine algal secondary metabolites, with
particular interest in their biomedical and agrichemical potential. Invaluable in such
pursuits have been the access and application of advanced spectroscopic techniques,
such as NMR, and the ability to assess the biological activity of the algal samples in a
variety of diverse protocols, through in-house evaluation and industrial collaborations.
As an in-house bioassay, a survey of algal extracts for molluscicidal activity has
led to the isolation of the previously reported chondrocole C (Portieria hornemanrn),
tanikolide (Ljyng1ya majuscula), and debromoaplysiatoxin (L majuscula).
Debromoaplysiatoxin is 100 times more potent than niclosamide, the commercially
utilized molluscicide.. Such activity may make debromoaplysiatoxin an attractive agent
for molluscan biological control to prevent the spread of schistosomiasis in artificial
waterways such as irrigation channels and rice paddies.
The isolation of chondrocole C led to further chemical investigations of P.
homemanni. A total of six related polyhalogenated monoterpenes were isolated from
Redacted for Privacythis collection. While four of these compounds were previously reported,
taviochtodene represents the newest member of this class of secondary metabolites.
Previously, this alga has yielded compounds with great potential anticancer utility, but
naturally and synthetically elusive. The discovery of this class of chemistry potentially
locates new geographic territory to search for such anticancer metabolites.
While there has been little reported biological activity attributed to the
malyngarnides, they form the most prevalent class of secondary metabolites isolated
from Ljngbja majuscula. To this list we have added malyngamides L, Q, and R. Of
particular note, malyngamides Q and R were the first rnalyngamides to have been
reported with altered stereochemistry at the vinyl chloride carbon. Subsequently, and
in part stimulated by this finding, this alternate stereochemistry has been defined for
some newly reported malyngamides.
Also from L majuscula, tortugin and lyngbyabellin B were isolated as toxic
cyclic depsipeptides. Both of these compounds displayed relatively potent biological
activity (brine shrimp and antifungal). Each possessing particular structural motifs
previously seen in invertebrate secondary metabolites, they lend further evidence for
cyanobacteria as the producer of many of the polyhalogenated compounds often
attributed tode novoinvertebrate biosynthesis.(c)copynght by Kenneth E. Milhigan III
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CHAPTER I.
GENERAL INTRODUCTION
The use of natural products for ceremonial and medicinal benefit predates
written history. Presumably deduced by observations of human health within hunter-
gatherer and early agrarian cultures, the medicinal power of natural materials was
passed orally through early healers until written pharmacopoeias wereestablished.1
This pursuit of natural products chemistry is present in every culture, and has aided or
led to the discoveries of salicylic acid (1), vinbiastine (2), digitoxin (3), and many other
commonly known modern medicinal products (Figure I.1).12 Particularly steadfast in
exploring and utilizing the healing properties present in nature, practitioners of
Traditional Chinese MedicineCM), Arvedic Medicine (India), and examples
within the Ebers Papyri (Egypt), and various tribal 'prescriptions' demonstrate a rich
history of success treating their patients using naturalproducts.12'3Such remedies
typically exist in crude form as combinations of ingredients. Modern Western
Medicine hasonlyrecently begun to unravel the mysteries held within these ancient
medicines. An obvious display of the respect held for these practitioners is the
International Cooperative Biodiversity Group (ICBG) initiated by the NCI and NIH
to explore the uses of natural products in the pharmacopoeia of the modernSource i)nig Utility
Filpendu1a ulmaria (Meadowsweet) Salicylic acid (1) analgesic, antiinflainmatory
Catbarantbus roseus (Rosy Periwinide) Vinbiastine (2) anticancer
DgitaIispurpurea (Foxglove) Digitoxin (3) congestive heart failure treatment
Papaver somn/èrum (Opium Poppy) Codeine (4) analgesic, antitussive
Cinchonapubescens (Fever Tree) Quinine (5) antimalarial
Datura stramonium (Jimsom Weed) Scopolamine (6) relieves motion sickness
CO2H
Salicylic add (1)
MeO2C".I
Me OH OH Digitoxin (3)
Vinbiastine (2) MeO2C
Codeine (4) Quinine (5)
Figure 1.1. Selected natural product drugs in common use.
0
N
Me
"O10
Scopolamine (6)
OH"Shaman", and investigations undertaken by the Natural Products Branch of the
Nd.4
The ICBG and NCNPDDG (National Cooperative Natural Products Drug
Discovery Group) programs supported through collaboration between the NIH, Nd,
pharmaceutical companies, and natural products scientists are an effort to increase the
already substantial use of natural products (terrestrial and marine) in pharmaceutical
therapy. Recently, it has been reported that natural products, derivatives of natural
products, and synthetic molecules inspired by or modeled upon natural products
comprise 39% of the newly approved drugs from 1984-1994. Thissame study
observed that 61% of the available anticancer therapies (1989-1995)were of that same
demographic as well. Further examination of both the terrestrial and marine worlds,
and the continued investigation of non-western pharmacopoeia will doubtless provide
many more medicinally beneficial natural products.
MARINE NATURAL PRODUCTS CHEMISTRY
Historically, the first commercially valuable marine natural product is Tyrian
Purple (7), an ancient Phoenician dye produced from the mollusc,Murex brandaris,
around 1600BCE.6Tyrian purple also has the distinction of being the first marine
natural product to have its structure successfully deduced. The powerful toxicity of
tetrodotoxin (8) (recently recognized as a sodium channelblocker)7'8is also supposed
to have been recognized in antiquity, as depictions of its source, the puffer fish
Tetraodon stellatus,can be found in Pharonic tombs of Egypt dating to around 2700
BCE.6The toxicity of marine fish, molluscs, echinoderms, and coelenterates is alsoBr)>
Br
Tyrian Purple (7)
.):i
Spongothymidine (9)
OH
OH
HOfLI1
OHHO H
Tetrodotoxrn (8)
o NH2
HN N
ON LNJN
HOH2CO HOH2CVO...,J\I
OH OH
Spongouridine (10) Ara-A (11)
OH
Ara-C (12)commented upon in records of the early Hellenic, Assyrian, Persian, Indian, and
Babylonian cultures.6 However, ensuing epochs and the lack of written records for
many cultures intimately associated with the oceans left few records of marine natural
product utility,.1'2'6 Technology, the search for novel scientific niches,a heightened
understanding of the ocean and its components, and the potential for profit, both
financial and medicinal, served to alter the landscape of marine natural products
research in the20thcentury.
Figure 1.2 highlights certain key facts concerning the marine environment that
began to pique the interest of natural product scientists. These factors provided
explorers with an alternative to exploring a terrestrial environment that had been the
subject of 5000 years of natural products pursuit. Making this unexplored frontier
accessible was the advent of technology that enabled underwater respiration (SCUBA).
Lending further impetus to marine expeditions was the discovery by Bergmann of
spongothymidine (9) and spongouridine (10), metabolites incorporating arabinose
instead of ribose, from the marine sponge Ctotethiac1jta.9From the structures of 9
and 10, Ara-A (11) and Ara-C (12) were synthesized into two of the most successful
commercial marine natural products. Ara-C is used to treat non-Hodgkin's lymphoma
and acute myelocytic leukemia, whereas Ara-A a pharmaceutical that treats herpes
infections.9'1°These occurrences combined to give academic birth to the field of
marine natural products chemistry in the early 1970s.h1,12'13 Available avenues of
funding were developed through the NIH, Nd, NOAA, National Sea Grant College
program, and NAIAD (National Institute of Allergic and Infectious Diseases), as well
as through collaboration with pharmaceutical companies.6'1113OCEANS...
cover 70% of earth surface
comprise 95% of tropical biosphere
contain more than 200,000 invertebrate and algal species
contain all but 2 of the 28 major animal phyla
possess a greater biodiversity at higher taxonomic levels
contain species that have existed for up to 3.5 billion years
possess dynamic ecological stratification
provide a medium for chemical communication which is superior to air
are 'the last great frontier on earth', with much of it yet to be explored!!!
Figure 1.2. Facts about the oceans that stimulated the pursuit of marine natural
2611-13 products chemistry.7
Despite a mere three decades of existence, marine natural products chemistry has
described the isolation of over 10,000 newcompounds,2quite a few of which hold
important promise as drug leads or moleculM probes (Figure 1.3 and Figure 1.4).
Apart from the tangible profitability that a new pharmaceutical product delivers, the
pursuit of marine natural products has resulted in the description of numerous
fascinating organisms and associations, and attaches academic and financial value toa
still largely unknown natural resource.
THE ALGAL DIwsIoNs
The algae are a diverse group of organisms, ranging in size from single-celled
cyanobacteria (blue-green algae) to the great brown algae of the kelp forests, andare
typically divided into four major divisions, brown (Phaeophyceae), red (Rhodophyta),
green (Chiorophyta), and blue-green (Cyanobacteria). The classification of algae is not
based upon visible color, but is predominately dependent on the type of chlorophyll,
accessory pigments, storage proteins, and cell wall composition employed by the alga
(Figure
J.5).14.15.16The taxonomic structure for algae is an often disputed topic, as
despite their photosynthetic capabilities they lack the appropriate characteristics to be
truly considered plants, and they show little phylogenetic relatedness between
divisions.14'15"6Also, difficulties exist in describing the cyanobacteria as bacteria or as
algae. Cyanobacteria, while capable of photosynthesis, lack organized organelles (thus
being prokaryotes) and apparently utilize some of the biosynthetic machinery extant in
bacteria and fungi. For taxonomic purposes herein, the cyanobactena will be referred
to as "algae."Source
Do/abel/a auricu/aria (Sea Hare)
Ecteinascidia turbinata (Sea Squirt)
Bugula neñtina (Bryozoan)
Lissodendoyx sp. (Sponge)
Discodermia dissoluta (Sponge)
Poplieria hornemanni (Red alga)
Jaspis spp. (Sponge)
Ljngbjia majuscula (Blue-green alga)
Lj'n,g/ya majuscula (Blue-green alga)
Dolastatin-lO (13)
Ecteinascidin 743 (14)
Bryostatin-1 (15)
Discodermolide (16)
Halichondrm B (17)
Halomon (18)
Jaspamide/Jaspakinolide (19)
Debromoaplysiatoxin (20)
Curacin A (21)
Anticancer
Anticancer
Anticancer
Anticancer
Anticancer/immunosuppressant
Anticancer
Anticancer/antifungal/molecular probe
Molecular probe
Antimitotic/molecular probe
Status
Phase II clinical trials
Phase II clinical trials (Europe)
Phase II clinical trials
Preclinical development
Advanced predlinical
Advanced preclinical
Advanced preclinical/commercially available
Commercially available
Predlinical trials
Figure 1.3. Selected examples of marine natural products with potential medicinal or research utility.2'4'6'1
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Their environmental plasticity is dramatic,as algae can be found from the depths of
the oceans (200-300 m) to the partially dry intertidal regions of the shore, and from
terrestrial soils, freshwater rivers, lakes, and even swimming poolsto mountaintops,
hot springs, and snowfields.14'15Equally varied are the types of organisms which prey
upon algae, and thus, algal survival has been made possible by a variety of defenses,
including structural, temporal, spatial, andchemical.17'18'19Structural defense can be
observed most clearly in calcified red and green algae, their
bodies being rendered impregnable to many predators bya tough calcium carbonate
exterior. Other algae have a life cycle which is opposite that of their predators, and
thus displaces them temporally fromdanger.'9An intricate method of temporal
defense is the utilization of a life cycle which consists of an alternation of generations.
The red alga Porpbjra sp., as well as many other red and brown algae, have
heteromorphic gametophyte and sporophyte stages with the large and leafy
sporophyte present in the winter season, shielded in time from the voracious molluscs
present in the summer season.20'' In situations such as this, the smaller gametophyte
stage overlaps with the periods of highest predation. However, this small size
increases the probability of being located in protected microhabitats, inaccessible to
predators much larger than itself; this is an example of spatialprotection.'9The
production of secondary metabolites which are distasteful or toxic to predatorscan
also conveyprotection.17"8"9These chemical defenses represent molecules sculpted by
time and evolution as potent weapons of survival for the organism, that can be utilized
and manipulated by man in our defense or treatment of disease.DivisionChlorophyll Accessory Cell Wall Storage Habitat
Pigments Product
Cyanophyta a phycoerythrin, peptidoglycan glycogen marine&freshwater,
phycocycanin adaptable therm
Rhodophyta a,d phycoerythrin, cellulose floridean marine&freshwater,
phycocyanin, starch temperate/tropical,
zeaxanthin to depth of 200 m
Chlorophyta a,b lutein cellulose, starch marine&freshwater,
pectin mostly freshwater,
cosmopolitan (freshwater),
polar&tropical (marine),
often intertidal
Phaeophyta a,c fucoxanthin cellulose laminarin mostly marine,
high intertidal
Figure 1.5 A comparison of the characteristics of the four major divisions of algae'6'3412
Algae are ancient organisms instrumental in the formation of the earth's
atmosphere, and as primary producers, contribute to thecurrent atmospheric oxygen
load.14'15They also form the base of the marine food web, supplyingan immediate
source of nutrients to filter feeders and herbivorous marine anmals.Apart from
these primary nutrient roles, the algae are of extreme importanceto two key structural
features of the oceans; the intertidal zone and coral reefs. In intertidal and coral reef
zones, algae transform a two dimensional rock formation into a 3-D habitat, thus
fostering ecosystem maintenance anddevelopment.54'15Continuing biological,
ecological, and marine natural product investigations, algaemay also someday be
responsible for the next generation of pharmaceuticals.
HUMAN USES OF ALGAE
Ancient healers recogni2ed the value of algae as a potent natural pharmacy.
The medicinal qualities of algae are extolled in the Ebers Papyrus (ancient Egypt),
ayurvedic medicine (India), and traditional Chinese medicine,as well as in some tribal
customs (the Inuit treat sore joints with an application of green algae) and Japanese
folkmedicine.3'22Such ancient medicinal uses of seaweed includes the promotion of
bone formation [Unda,ia spp. (Wakame)], and treatments for parasites (Dgenea spp.),
gout and goiter (Laminaria spp.), sexually transmitted diseases (Dumontiaceae), and
cancer.3'24Brown algae, specifically Laminaria spp. and Sargassum spp., were used by
Egyptian, Chinese, Japanese, and ayurvedic medical practitioners to treatcancer, and
were particularly mentioned in the Ebers Papyrus for their efficacy in treating breast
cancer.2125The traditional use of Dzgenea spp. as an antiparasitic led to the discovery of13
kainic acid (22), a small molecule used in treatments of roundworm, whipworm, and
tapeworm infections, and as a biochemical tool due to its potentneurotoxicity.'5
Modern uses of algae and algal products are more common thanmany would
suspect. Polysaccharides of brown and red algae are used extensively in science and
the food industry, in products such as agar, toothpaste, gelatin, and icecream.'6'2126
The commercialization of such products produces an annual revenue of approximately
$250miffion.16Carageenan is one such commercially important polysaccharide that
also has folk-medicine applications as an anticoagulant and cancer-fightingagent.26
Antiviral Dumontiaceae (red algae) carbohydrates, includingcarageenan and
dextran sulfate, among others, were found effective (pre- and post-infection) against
herpes I and ii in human clinical trials, both topically and orally, withno observed sides
effects.2126Despite these promising results, Dumonthceae-derived compounds have
not yet cleared the high hurdles of the drug approval process, and thus have been
relegated to the ranks of alternativemedicines.2126
FRESHWATER ALGAE
Another hopeful development is the isolation of a protein from the freshwater
cyanobacterium Nostoc el1psoiporum that may also play a role in the fight against a
sexually transmitted virus. Cyanoviran-N (CV-N), a small uncomplicated protein (101
amino acids) whose function in nature, if any, is still unknown, acts in the laboratory
as a "fusion inhibitor" of the human immuno-deficiency virus(HIV).27CV-N forms
an irreversible complex with the gpl20 surface-receptor molecule of HJV, stripping
the virus of its ability to penetrate and infectcells.27The CV-N binding site of gpl2Oi
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may be a common retrovirus motif, as this complex (and subsequent cessation of viral
activity) is observed in all laboratory strains of HIV, including HJV-2, SW(simian),
and FIV (feline)
27CV-N is unaffected by heating, freezing, thawing, acidification,and
denaturing, adding to its attractiveness as a medicaltreatment.27
Despite these advantages, the formation of antibodies against foreignproteins
like CV-N limits its potential therapeutic utility; thus, CV-N is likelyto be most useful
as a barrier toinfection.27'28Using biotechnological tools, the genetic code responsible
for the production of CV-N could be spliced into Lactobacillus,a common, necessary,
and beneficial microbe of the vaginal mucosa. The resulting culturewhichwould be
administered in suppository formwould createa fortified infection barrier, having
the advantages of both the low pH produced by lactic acid (secreted byLactobacillus)
and the fusion-inhibiting action ofCV-N.27'28
The cryptophycins, secondary metabolites found in thesame genus of
freshwater cyanobacteria responsible for CV-N, have been shownto possess
antifungal and anticancer activity.The active molecules are small, cyclic
depsipeptides originally isolated from Nostoc spp. following antifungal activity.
However, they may have more potential utility in the anticancerrealm.29Cryptophycin
1 (23) is an extremely potent antimitotic agent that binds nearly irreversiblyto tubulin
(a cytoplasmic protein), thus inhibiting microtubule dynamics and preventing the
uncontrolled proliferation of cells that characterizescancer.29The action of
cryptophycin 1 is similar to that of vinblastine (2),a drug derived from the Madagascar
rosy periwinkle, and used to treat breast and testicular cancer and Hodgkin's disease.16
Both compounds act at the ymca alkaloid site, but the former isan even more potent
stabilizer of microtubule dynamics. In fact, it is the most powerful suchagent yet
found. In animal tests, analogs of cryptophycin 1 have "cured"some types of
tumors.29One such analog, cryptophycin 52 (24) has advanced to Phase H clinical
trials, and may someday be a new cancer treatment.
MARINE ALGAE
Like their freshwater cousins, marine blue-green algaeare also a source of
potentially powerful pharmaceuticals. Curacin A (21) isa lipopeptide isolated from a
sample ofLjvn,gbya majusctilacollected on the southwestern Caribbean island of
Curaçao.3°An extract containing curacin A displayed striking toxicityto goldfish,
brine shrimp, and snailsas well as cancer cells. The pure isolate of curacin A
destroyed cancer cells by inhibiting microtubule formation, similar to the action of
colchicine.3°However, curacin A has not progressed on the "drug pipeline" dueto
problems with stability and solubility. Research is currently underwayto alleviate these
problems and further test this powerful chemical. Incidentally, the discovery of
curacin A has yielded ecological as well as pharmaceutical benefits. Themangrove
swamps from which the curacin A producing alga had been collected were destined to
be replaced by a coastal resort development. Because of curacin A'sgreat
pharmaceutical potential, however, the development was cancelled and themangrove
habitat waspreserved.31
Kalkitoxin (25), another product of L majuscula, is a potent toxin to brine
shrimp, rat neurons, and goldfish, an inhibitor of fertilized sea-urchin-embryo cell17
division, and an antagonist of hepatocarcinoma proliferation invitro.32Kalkitoxin is
among the most potent neurotoxins ever discovered. Like topiramate (a
pharmaceutical used in the treatment of epileptic seizures) and lidocaine (an analgesic),
kalkitoxin acts as a sodium-ion channelblocker.32Saxitoxin (26), a very potent
dinofiagellate neurotoxin responsible for numerous closings of the shellfish industry
of the northwest U.S. coast, acts at the same site, but is one-tenthas potent. Such
potency suggests kalkitoxin could have great potential as a molecular probe.
Algae such as L majuscula afford us the opportunity to study and manipulate
the biosynthetic machinery that creates such potent secondary metabolites. Curacin A
and kailtitoxin are both products of mixed biogeneses, combiningaspects of the
polyketide synthase and non-ribosomal peptide synthetasepathways.33Both pathways
have been shown to possess clustered genetic machinery composed of modules,
creating its products on a metabolic assembly line. Efforts are underway at Oregon
State University and the University of Minnesota to probe and manipulate these
pathways in cultured specimens to better understand the organisms and the
biosynthetic pathways, and to potentially create even more potent chemicals.
Apart from their ability to seed our atmosphere with oxygen, and their
necessary functions as valuable members of coral reef communities, algae present us
with a chemical cornucopia of potential pharmaceuticals. With this inherent wealth of
metabolic machinery, they provide us with a template which can be manipulated
through culture techniques and the burgeoning power of molecular biology to create
the next generation of pharmaceuticals to combat human diseases. Such tremendous
value could lead one to envision the farming of these organisms to the detriment of18
their natural ecosystems, and, by extension, to all ecosystems. However,as
exemplified by the power of curacin A to protecta stretch of Curaçao's mangroves,
knowledge of the diversity extant withinour oceans, the understanding of the
relatedness and dependence of all organismsupon each other, and the potential
medicinal treasures, made possible only by such diversity,can serve to protect rather
than endanger.
THESIS STATEMENT
Algae are sessile organisms often encountered inareas of intense species
diversity andherbivory.171°As such, many have developed methods of defensemost
suitable for their local habitats. Chemical defenseseems to be the defense of choice
for smaller slow growingalgae.1719Since such secondary metabolites have been honed
by evolutionary forces to be biologically active compounds, theyrepresent a
downstream stage of the "natural drug discovery process." The investigation of the
secondary metabolites present in natural systems has two valuableoutcomes, 1) an
enhanced understanding and appreciation for the natural environment, witha
heightened awareness of the intricate processes thatare present yet barely understood
and 2) a contribution to the drug discovery process by uncovering both biologically
active and inactive secondary metabolites produced by biosynthetic pathways that,
while originally protecting more primitive organisms, may lead to thenext generation
of pharmaceuticals which aid humans. As such, the overarching hypothesis of this
work is that marine algae produce metabolites, which can be isolated and chemically19
defined, that will enhance the understanding of marine algae and their products and
will play a necessary 'front line' role in drug discovery efforts.
GENERAL THESIS CONTENT
The focus of this thesis is the isolation and structure elucidation of secondary
metabolites from marine algae (macrophytes and cyanobacteria). Threecomponents
have proven invaluable in this pursuit; a library of crude extracts representing algae
collected from locations circumnavigating the globe, the ability to examine the
biological activity of these samples (both in-house and through extensive academic
and industrial collaborations), and the application and, whennecessary, creation of
technology to properly identify the structure of the component of interest. In the
shadow of this general introduction can be seen a common braid thatweaves itself
through each chapter in an attempt to unravel, identify, and qualify what isextant in
nature. The goal of all such work is a contribution to the drug discovery process, the
scientific archive, and our general understanding of existing naturalprocesses.
As such, after this general introduction, the thesis begins witha survey of algal
extracts for molluscicidal activity against Biompha1ariag1abrata, the intermediate host
for the schistosomiasis causing worm, Sthistosome mansonii. One method of disease
prevention (especially in artificial waterways such as irrigation channels) is to control
the population of the snail. Currently, niclosamide is the commercially utilized
molluscicide. Pursuing activity discovered through this survey, tanikolide,
chondrocole C, and debromoaplysiatoxin were purified and identifiedas the active
constituents of their respective extracts. Debromoaplysiatoxin possessedmore20
potency than niclosamide, and may have utility in efforts to stop the spread of
schistosorniasis.
The re-discovery of chondrocole C as a molluscicidal secondary metabolite
inspired the work described in Chapter III. In total five polyhalogenated
monoterpenes were isolated from a collection of Portieria bornemanni, with one of them
being the newly described compound, taviochtodene. The small size and chemical
shift similarities within this structure class called for extensive utilization ofmass
spectrometry (especially GC/MS) and NMR experiments to accurately determine
chemical structures. P. hoemanni is the original source for halomon,a rare and highly
potent secondary metabolite with anticancer potential, that has not proceeded down
the drug pipeline because of its scarcity and synthetic complexity. A close chemical
relative of halomon, 2-dechlorohalomon (slightly less active incancer studies than
halomon) was among the isolated compounds.
Moving from the red algae to cyanobacteria, Chapter IV details the discovery
of three new malyngamides. The malyngamides are the most prominent class of
Ljng/ya majuscula secondary metabolites. To this list have been added malyngamides L,
Q, and R. While malyngamide L shares many characteristics of the standardly
encountered cyclohexyl-type malyngamide, malyngamides Q and R offeredsome
intriguing differences. Firstly, they are structurally similar to malyngamides A and B,
members of the less common pyrrolidone-type subclass of malyngamides. Also,
malyngamides Q and R were the first malyngamides discovered withan alternative
geometric stereochemistry at the vinyl-halide carbon.21
Iyngbja majuscula secondary metabolites are also the topic of the penultimate
chapter, Chapter V. A Dry Tortugas sample of L majuscula yielded two toxic cyclic
depsipeptides, lyngbyabellin B and tortugin. Lyngbyabellin B, toxic to brine shrimp
and Candida albicans, is a dichiorinated compound resembling the molluscan-derived
metabolite dolabellin. Tortugin, displaying activity against brine shrimp, incorporates
a seldom encountered terminal acetylene residue which has most commonly been
observed in a series of molluscan secondary metabolites.
A summary of the presented work on marine algal natural products chemistry
appears in the concluding Chapter VI. Specifically highlighted are the topics running
through each chapter that tie them together as one work. Also summarized is the
attempt of this work to unravel, identify, and qualify what is extant in nature in the
hopes of contributing to the drug discovery process, the scientific archive, and our
general understanding of existing natural processes.22
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CHAPTER II.
MOLLUSCICIDAL ACTIVITY IN MARINE ALGAL EXTRACTS;A SURVEY AND
CHEMICAL INVESTIGATION OF PROMISING MouuscIcIDALALGAL
EXTRACTS
ABSTRACT
Schistosomiasis is a parasitic disease endemic inmany of the world's
developing nations, and victimizes hundreds of millions of people.The
causative trematode, Schistosoma spp., hasproven quite adaptive to commonly
administered therapies, developing refractile resistanceat an alarming pace. In
response to a lack of potentizl new and affordable pharmaceutical alternatives,
the World Health Organization is advocating the search for toxins that
specifically target the freshwater snail, Biompba1aria1abrata, whichserves as the
obligate intermediate host for the schistosome larvae,as a method of disease
control. As marine algae are thought to employ at leastsome of their myriad
secondary metabolites in combating predation, with aquatic molluscs being
dominant herbivores and potentizl targets, it is possible that the chemical
extracts of marine algae possess compounds that are toxic to freshwater snails.
Therefore, this chapter reports the screening of marine algal crudeextracts for
their toxicity to B. glabrata. Following analysis of the results, the active
constituents of some of the most highly potent extractswere isolated in a
bioassay guided manner, yielding the previously discovered chondrocole C,
tanikolide, and debromoaplysiatoxin.26
INTRODUCTION
Schistosomiasis, also known as bilharziasis, isa disease that afflicts 200-300
million people, in regions spanning the globe.3539 A furtherfive to six million people
remain at high risk of contracting the disease,as it is endemic in 74 countries.33
Children and some agricultural laborers bear thegreatest burden of disease among
demographic groups due to age or occupation related activitiesincreasing the
probability of contact with theschistosome.2Such high-risk populations are
especially prevalent in countries with rapidly developinginfrastructures, such as Egypt
and China, where public works projects have playeda role in the epidemiology of
schistosomiasis31
While schistosomiasis is typically not life threatening, the effectsare often
chronic and can lead to disability, representinga significant drain on both the human
and economic resources of affected countries.38 Asa public health issue,
schistosomiasis is a worldwide concern, and ranks second onlyto malaria in socio-
economic and human health importance in tropical nations.3539
The disease is caused by one of five schistosome species (Figure11.1); S.
mansoni, S.japonicum, S. meIeongi, and S. intercalatum whichcause intestinal
schistosomiasis, and S. haematobium which is responsible for urinaryschistosomiasis.
These differences in disease manifestationare due to the habits of the individual
trematode species for location of egg deposition.37°27
Species Location
S. ,rnznsoni Africa, Eastern Mediterranean,
Caribbean, South America
S.japonium and South-East Asia and Western Pacific
S. ,nekongi
S. inteivalatum Central Africa
S. haematobium Africa and Eastern Mediterranean
Tvne of Schistosomiasis
Intestinal
Orientalor
Asiatic Intestinal
Intestinal
Urinary
Figure 11.1. The five spp. of schistosomiasis causing trematodes.4028
THE DISEASE
Disease symptoms and complications are primarily the result of immune
responses to antigens secreted by the schistosomeeggs.45'6In acute schistosomiasis,
Katayama fever, a sudden high influx of antigen, which typically coincideswith egg
deposition, causes symptoms such as epidermal rash, asthma, fever,diarrhea, and
malaise. Extremely heavy infectionscan also result in death. Fever and diarrhea also
accompany chronic schistosomiasis, as does hepatosplenomegaly, liver fibrosis,
hepatoportal hypertension, and esophageal 1esions.45'Children also have reduced
growth rates as a result of thechronicform of this disease. Urinary schistosomiasis
has the additional complications of pyelonephritis, hydronephritis,and bladder
fibrosis, which can lead to ureter obstruction and/or kidney failure.Liver, bladder,
and intestinal cancer are also a potential result ofseverechronic schistosomiasis.45'46
TRANsMIssIoN
Schistosomiasis is caused by parasitic trematodes that live and reproduce inthe
blood ofmamma1s.3Within the mammalian host, the female depositseggs in the
veins surrounding the bladder or intestines, dependingon the infectingspecies.45The
eggs are released into the environment when the mammal excretes or defecates. If
within, or near, a body of water, or in cases of waterways polluted bywastewater, the
eggs hatch and proceed to the next stage of their life cycle (Figure 11.2)
3942,
When delivered to water the eggs hatch into their first larval form, the
miracidia.3539The miracidia is a free-swimming larva capable of infecting only the
intermediate host, the snail. In the laboratory, miracidia have been shownto beadult worms mate and deposit eggs,QMammalian I-lost
causing symptoms of Schistosomiasiç
cercariae migrate within host to optimal location
swimming cercariae enter skin of mammal
cercariae emerge from daughter
sporocysts and escape from snail
Free swimming
encapsulated embryos released in feces
Free swimming
miracidia hatch in fresh water
)Miracidia presumably locate
J snail host by following a chemical
-'gradient
miracidia invades snail
mother sporocysts develop Within Snail Host (Obligate snail to produce daughter sporocysts
intermediate)
Figure 11.2. The life cycle of Schistosomaspp.30
negatively photo-tactic, thus facilitating the location of snails crawling along the
bottom of the waterway.47'48 It also appears that the miracidia respondto exuded
metabolites of the snail, thus finding their host by traversing alonga chemical gradient.
The nature of the sensory chemical(s), however, is yet to be discovered.47M Within the
snail, the miracidia undergoes metamorphosis, forming numerous cercariae.339
The cercariae emerge from the host as pathogenic parasites that exhibit
positive photo-taxis, presumably increasing the probability of encountering mammals
in shallow water.47'48 The infective larvae penetrate the exposed skin of their
mammalian host then mature and reproduce. Each day hundreds ofeggs are
produced by the female; many causing the symptoms typically encountered, and the
rest being released into waterways by the mammal, thus perpetuating the cycle of
infection.353'
METhODS OF CONTROL
There exist three areas of focus for the control of schistosomiasis, all used in
various degrees and levels of success, and which target different aspects of the disease
or transmission of the disease. Figure 11.3 highlights the methods of control currently
utiIized.3741'479
The most common form of control is treatment of the patient after having
been infected by the trematode, or by application of immunization programs. Figure
11.4 shows the current drugs used to treat schistosomiasis. While praziquantel (27) is
the current drug of choice, and has been highly successful, refractile resistance to 27 is
becoming alarmingly prevalent.378'4042 Such resistance suggests an adaptive ability ofMethod of Control
Treatment; in human, post-infection
Chemotherapy; praziquantel
Immunization
Pre-Infection; preventing interaction of man &
pathogenic schistosome
Environmental Infrastructure; Improve sanitation
Pre-Activation; inhibiting contact between schistosome larvae
and obligate intermediate host
Molluscicides; Niclosamide (remove host snails)
Aquatic Controls; Dry canals ("drown schistosomes")
Biological Control; Species Introduction
Marisa cornuaieIis
Molluscan competitor
Difficulties with Treatment
>Costly, Refractile resistance
>Not yet possible, Risk of spreading
other diseases
>Economically costly, Encysting stages of life cycle
->Reniigration of snails, Environmental toxicity
>Costly, Difficult to implement
>Potential environmental disaster, Adaptability of
schistosome
Figure 11.3. Methods used, or proposed, to control the spread of schistosomiasis.3741'4749
L)32
the schistosome that may necessitate renewed interestin the development ofnew anti-
schistosomiasis drugs. An additional problem encounteredwith pharmaceutical
treatment of schistosomiasis is that it is oftena cost prohibitive solution in areas
where it is most needed. Other useful pharmaceuticalsemployed in the treatment of
schistosomiasis are oxamniquine (28) and metrifonate (29).°The use of
immunization programs is a goal ofmany affected countries, but has not yet seen
broad application. It has, however, received intense interestfrom the WHO, and
shown potentialutility.40
A second method attempts to limit the interaction ofhumans and
schistosomes, thus preventing infection. As the spread ofthe disease is assisted by
waterways being polluted by human waste, or the waterways themselves servingas the
primary conduits of waste, some countriesare attempting to improve their sanitation
infrastructure. This, however, is an extremely costlyventure further exacerbated by
large populations living in distant and decentralizedregions.32
The third method of control is aimed at disrupting thesuccessful completion
of the schistosome life cycle; thus blocking the activation ofhumanpathogenicity.37°
This effort has witnessed three focal points of attack, molluscicidal,environmental,
and biological methods of control. Usedas a molluscicidal agent, niclosamide (30) has
been introduced into many waterways, resulting in death ofmany snails and other,
non-target,invertebrates.343Problems encountered using niclosaniide include
environmental toxicity and the re-migration of snails after inoculationwith the
compound.48Also, 30 is a very stable molecule, resistant to changes in pHand33
temperature, thus stimulating concern for environmentalaccumulation.48Of course,
in many areas the cost of niclosamide limits its utility.
Attempts have also been made to alter the environment of the schistosome by
draining waterways, and thus "drowning" the snails and schistosomes inair.37°'48'49
This method has had very limited success due to the ability of the schistosomes to
form encysting bodies which yield viable trematodes upon reintroduction of water and
snails.48There are also obvious financial problems associated with this method,as the
resources needed to accomplish it are extraordinary, and the disruption of the
waterways results in significant economic hardship for many of the affected areas.
Biological controls have proven only slightly more successful. The
introduction of a competitor toB. ,glabrata,the mollusc Mania con'zuanietis, has limited
the viability ofB. glabrataby competing for itsresources.48'49Exotic species
introduction, however, is a troublesome initiative to support, as ecological disasters
appear to occur as a frequent result of suchendeavors.51
SCHISTOSOMIASIS; 'THE SCOURGE OF DEVELOPING NATIONs"
Schistosomiasis has been called 'the scourge of developingnations'.49This
moniker is due to the dramatic rise in disease incidence that accompanies public works
projects, specifically water resource development, such as dam building and the
creation of irrigationsystems.49The construction of dams and man-made lakes,
usually for hydroelectric power, results in stagnant water that has a higher temperature
than if it were allowed to flowfree1y.45°The fecundity of both the snail and worm is
much more robust under such stagnant and warmconditions.49'5°Therefore, a34
population explosion could be expected which wouldlead to an increased incidence of
disease in the immediate vicinity of thestagnant water, as well as in those regions that
receive this water. As a confoundingconsequence, irrigation systems derive their
resources from the dammed and man-made lakes, thereby delivering thesnails and
worms to regions that typically would have a decreased likelihood of schistosomiasis
incidence. These irrigation systemsare often supporting rice paddies, and othercrops
that require immersion or floating techniques, thus significantlyincreasing the
exposure of the workers in the fields with the infectiveorganism.5°Figure 11.5
highlights a few worldwide examples of the effects ofdeveloping infrastructureupon
schistosomiasisincidence.49Aside from public works projects, civil strife (resultingin
mass population movements into or out of endemic areas) and "off-tracktourism" are
also responsible for the increased incidence ofschistosomiasis.48'49
THE POTENTIAL USE OF CHEMICAL ECOLOGYAS A METHOD OF CONTROL
Laboratory experiments have proven the effectiveness ofsnail-conditioned
water (SCW) in the attraction ofmiracidia.5158While the chemical structure of
this/these chemoattractants has yetto be fully explored, size exclusion filtration and
hydrolysis experiments have suggested that the compound(s)possess a molecular
weight below 1000 da and are of a peptidenature.51'58Analyses of SCW by HPTLC
and free amino acid analysis have describeda chemically-rich effluent of various
neutral fatty acids, free fatty acids, and free aminoacids.53While these free amino
acids may be partially active as chemoattractants, the fullyactive component appears
to be a small oligopeptide due to loss of chemoattractant activity afterhydrolysis.53A35
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Figure 11.4. Praziquantel (27), oxamniquine (28), and metrifonate (29),
three chemotherapeutic agents used to treat schistosomiasis infection, and
niclosamide (30), the most common commercially utilized molluscicidal
agent.
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detailed understanding of the specific chemical components of snail effluent is lacking
and the potential for non-peptidic chemoattractants, as well as multiple
chemoattractants, remains possible. Detailed analysis of this complex interaction
between miracidia and snail would provide a powerful tool to control schistosomiasis,
allowing the manipulation of their chemical ecology to short-circuit the life cycle of
the trematode. Such a control system would mimic the attractive qualities of SCW
(taking advantage of the chemosensory aspect of host location) from a locationnear
the bottom of a waterway (using the negative photo-taxis of the miracidia to aid
control), leading the miracidia into the mimic, where they could then be destroyed. By
removing large numbers of miracidia from the waterway disease incidence would be
decreased dramatically.
In the treatment of established ecosystems, the ecologically optimal course of
action will use control methods other than the introduction of foreign species or
molluscicidal agents. However, in artificial waterways such as irrigation channels and
rice paddies, the use of molluscicides could represent the best, and most efficient,
solution presently available. While niclosamide has been used effectively for decades,
further research into molluscicidals could develop an alternative that would be more
potent and selective and less expensive, thus decreasing the contraction of
schistosomiasis in developing nations.37
RESULTS AND DISCUSSION
Marine algae have proven themselves to be dynamic producers of secondary
metabolites of structural novelty and potent biological activity. Whileyet difficult to
prove categorically, it is believed that many of these secondary metabolites participate
in the chemical defense of algae against herbivorous predators. As molluscsare
dominant marine herbivores, algal survival would seem to indicate defensive
capabilities against these predators. By extension, the potential exists that algal
secondary metabolites could display molluscicidal activity against the freshwater snail,
Biomphalaria g1abrata, evolutionary "cousins" of marine molluscs. To begin exploring
this, a panel of marine algal extracts was screened for toxicity to B. g1abrata. The
objective of this screening effort was two-fold, 1) to providesupport for the
hypothesis that marine algae produce molluscicidal secondary metabolites, and 2)to
define algal extracts of high potency, enabling the isolation and structure elucidation of
new molluscicidal components that could be useful in the treatment of snail infested
waterways.
MOLLUSCICIDAL SCREENING
Using the previously described molluscicidal assay (Figure 11.6),a total of 90
algal samples were examined for activity against B. labrata (Table II.1).Algal samples
tested were derived from tropical locations ranging in depth from 0-30m. All four
major algal divisions (red, brown, green, blue-green) were represented to varying
degrees (Figure II.7.a), predominantly based on the availability of extract. Themost
commonly tested algae in the survey were cyanobacteria and red algae.38
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Figure 11.6. The molluscicidal bioassay protocol, (A) add 9900 jtl of H20to
scintillation vial, (B) add 100 pl of premade test solution, () adda pair of
B. glabratasnails, (D) lightly cap and allow 24 hr then examine for snail toxicity.Table 11.1. Crude algal extracts examined in molluscicidalsurvey.
Gerwick Lab# Organism TypeStock# Depth Collected Location Collected
1 MNS-8/Apr/97-02Lygbya BG WG-EXT-10582 meters Madagascar
2 MNA-5/Apr/97-02Ljngbja BG WG-EXT-10621-3 meters Madagascar
3 MNT-6/Apr/97-01Lyg1ya majuscula BG WG-EXT-10836-7 meters Madagascar
4 MSL-1/Apr/97-08 Blue green BG WG-EXT-1 1330-1 meters Madagascar
5 MNS-8/Apr/97-03Ljngbja majuscula BG WG-EXT-1 1532-3 meters Madagascar
6 MNA-5/Apr/97-01Scbiotbrix BG WG-EXT-11441-4 meters Madagascar
7 MNA-5/Apr/97-03sea grass/epiphytic blue greenBG WG-EXT-10810-1 meters Madagascar
8 MSL-1 /Apr/97-08Blue green BG WG-EXT-1 1330-1 meters Madagascar
9 VTI-10/Feb/97-01Ljngbja BG WG-EXT-10403-4 meters Fiji
10 VYI-6/Feb/97-04Ljngbja/Schiothrix BG WG-EXT-10642-3 meters Fiji
11 VYI-5/Feb/97-02Lyzg/ya/Sthiotbrix BG WG-EXT-10660-2 meters Fiji
12 VYI-3/Feb97-01 Sthiothrix-Lngbja BG WG-EXT-1 1393-5 meters Fiji
13 MAM-10/Apr/95-01Ljngbja BG WG-EXT-1203 Madagascar
14 PNVB-6/Sep/98-02Lyngbja majuscula BG WG-EXT-12090-1 meters Papa New Guinea
15 PNHV-l1/Sep/98-01Blue-green algae BG WG-EXT-12150-1 meters Papa New Guinea
16 PNSB-5/Sep/98-02Lj'ngbja BG WG-EXT-12200-1 meters Papa New Guinea
17 APO-22/Nov/98-01Ljngbja mix BG WG-EXT-12450-1 meters Japan
18 PNHL-9/Sep/98-02Lyngbja majuscula BG WG-EXT-12325-8 meters Papa New Guinea
19 PNFP-8/Sep/98-05Blue-green BG WG-EXT-12420-1/3 meters Papa New Guinea
20 PNHL-9/Sep/98-08blue green algae BG WG-EXT-12550-1 meters Papa New Guinea
21 PNSM-4/Sep/98-01blue green algae BG WG-EXT-12570-1 meters Papa New Guinea
22 PNLI-10/Sep/98-04blue green algae BG WG-EXT-12610-1 meters Papa New Guinea
23 VTI-1 1 /Feb/97-02Schpthrix-frngbj,a BG WG-EXT-1 18911-12 meters Fiji
24 HBP-14/Mar/98-01Lj'ng/j'a BG WG-EXT-1205 Japan
25 MLK-2/Apr/97-01Laurencia R WG-EXT-10740-1 meters Madagascar
26 MSL-1/Apr/97-10red algae R WG-EXT-10750-1 meters Madagascar
27 ZAK-27/Mar/97-05Spiridea cupressina R WG-EXT-1080drift South Aftrica
28 ZAK-27/Mar/97-01Gelidiu,n R WG-EXT-1082drift South Aftrica
29 ZAK-27/Mar/97-03Rhodophjllis neptans R WG-EXT-1085drift South AftricaTable 11.1 (Continued). Crude algal extracts examined in molluscicidalsurvey.
Gerwick Lab# Genus speciesStock# Depth Collected Location Collected
30 ZAR-28/Mar/97-01Gigarlina minima R WG-EXT-10890-1 meters South Aftrica
31 ZAT-26/Mar/97-03red algae R WG-EXT-10910-1 meters South Aftrica
32 ZAK-27/Mar/97-06Plocamium coraiorhia R WG-EXT-10770 meters South Aftrica
33 MSL-1 /Apr/97-04Laurencia R WG-EXT-1 1280-2 meters Madagascar
34 MSL-1 /Apr/97-05red algae R WG-EXT-1 1290-1 meters Madagascar
35 ZAC-25/Mar/97-01G:gartina type R WG-EXT-10980-1 meters South Aftrica
36 MSL-1 /Apr/97-07Halimenia R WG-EXT-1 1260-2 meters Madagascar
37 MSL-1 /Apr/97-06red algae R WG-EXT-1 1350-2 meters Madagascar
38 VYI-5/Feb/97-07red algae R WG-EXT-10992-3 meters Fiji
39 VSS-7/Feb/97--01 Ataragopsis laxtiormis R WG-EXT-1 1526-7 meters Fiji
40 VYI-2/Feb/97-07Galaxauria R WG-EXT-1 1613-5 meters Fiji
41 VYI-2/Feb/97-05red algae R WG-EXT-1 1633-5 meters Fiji
42 VTI-6/Feb/97-01 Por%ie,ia hornemanni R WG-EXT-1 1772-3 meters Fiji
43 VYT-6/Feb/97-02red algae R WG-EXT-1 1792-3 meters Fiji
44 VTI-1 1/Feb/97-05Halimenia R WG-EXT-1 1803-4 meters Fiji
45 MFM-31/Mar/97-01red algae R WG-EXT-1 1430-1 meters Madagascar
46 MFM-31/Mar/97-03Chond,vcoccu.c R WG-EXT-1 1450-1 meters Madagascar
47 MSL-1 /Apr/97-03Rhodopellis types R WG-EXT-1 1512-3 meters Madagascar
48 MDS-3/Apr/97-03Hafymenia R WG-EXT-11550-1 meters Madagascar
49 VTI-1O/Feb/97-02Titanophora weberae R WG-EXT-1 1834-7 meters Fiji
50 MSL-1/Apr/97-02Bostrychia R WG-EXT-12000-1 meters Madagascar
51 PNSB-5/Sep/98-01Chondococcus homewannae R WG-EXT-12213-10 meters Papa New Guinea
52 PNSB-4/Sep/98-04Ceratodicyon R WG-EXT-12221-2 meters Papa New Guinea
53 PNSB-4/Sep/98-05Hafvmenia R WG-EXT-12230-1 meters Fiji
54 VSS-7/Feb/97-02 red algae R WG-EXT-11862-3 meters Fiji
55 VYI-5/Feb/97-08plocamium? R WG-EXT-1 1872-3 meters Fiji
56 VYJ-5/Feb/97-06red algae R WG-BXT-1 1882-3 meters Papa New Guinea
57 PNVE-6/Sep/98-06PyssoneIia R WG-EXT-123610 meters Papa New GuineaTable 11.1 (Continued). Crude algal extracts examined in molluscicidalsurvey.
Gerwick Lab# Genus speciesStock# Depth Collected Location Collected
58 PNSB-4/Sep/98-03red algae R WG-EXT-12390-1 meters Papa New Guinea
59 PNSB-4/Sep/98-02Haljmenia R WG-EXT-12490-1 meters Papa New Guinea
60 PNVB-6/Sep/98-03Coraimna red alga R WG-EXT-125110 meters Papa New Guinea
61 PNSM-4/Sep/98-03Red algae R WG-EXT-12520-1 meters Fiji
62 VYI-5/Feb/97-05 Peysonnellia cou4'/èra R WG-EXT-1 1912-3 meters Fiji
63 VYI-2/Feb/97-03 Plocamiun, R WG-EXT-1 1923-5 meters Fiji
64 VYJ-1 1 /Feb/97-08Zellera tawallina R WG-EXT-1 1933-7 meters Fiji
65 VYJ-5/Feb/97-03 Vidalia obtusiloba G WG-EXT-1 1992-3 meters Fiji
66 VTI-l1/Feb/97-03Flahaultia tegetifirmis G WG-EXT-12013-4 meters Fiji
67 MLK-2/Apr/97-02filamentous green G WG-EXT-10730-2 meters Madagascar
68 ZAM-28/Mar/97-03Halimeda cuncata G WG-EXT-10610-2 meters South Aftrica
69 M1DS-3/Apr/97-01Codium (encrusting) G WG-EXT-10970-1 meters Madagascar
70 ZAM-28/Mar/97-02Cauleipafihiformis G WG-EXT-10923-4 meters South Aftrica
71 VTI-1 1 /Feb/97-04Halimeda discoidea G WG-EXT-1 1003-4 meters Fiji
72 VYJ-2/Feb/97-02 Tydemania espeditionis G WG-EXT-117213-14 meters Fiji
73 VTI-11/Feb/97-07Boodlea coacta G WG-EXT-11733-4 meters Fiji
74 VTI-9/Feb/97-03 Avrainvillea G WG-EXT-1 17413-14 meters Fiji
75 VTI-3/Feb/97-07 Diqyosphaeria verslejysii G WG-EXT-1 1762 meters Fiji
76 MNS-8/Apr/97-01Halimeda "crink" G WG-EXT-1 1470-1 meters Madagascar
77 VY.l-3/Feb/97-04 Chiorodesmis G WG-EXT-1 1822 meters Fiji
78 PNTD-8/Sep/98-02Avrainvillea G WG-EXT-121726-30 meters Papa New Guinea
79 VYT-4/Feb/97-03 Halimeda G WG-EXT-11842-3 meters Fiji
80 PNNI-7/Sep/98-03Tydemanea expeditionalis G WG-EXT-122513-14 meters Papa New Guinea
81 PNwB-3/Sep/98-01Halimeda maavloba G WG-EXT-12281-4 meters Papa New Guinea
82 VYT-3/Feb/97-03 Tydemania espeditionis G WG-EXT-119816-17 meters Fiji
83 ZAT-26/Max/97-02Zonaria subarticulata B WG-EXT-10880-1 meters South Aftrica
84 VYI-5/FEB/97-04Padina minor B WG-EXT-1 1152-3 meters Fiji
85 VYI-4/Feb/97-06 Padina minor B WG-EXT-1 1682-3 meters FijiTable 11.1 (Continued). Crude algal extracts examined in molluscicidalsurvey.
Getwick Lab# Genus speciesStock# Depth Collected Location Collected
86 VYT-2/Feb/97-04Laminaria catenata B WG-EXT-1 1713-5 meters Fiji
87 VYI-3/Feb/97-06 Turbina,ia B WG-EXT-1 1812 meters Fiji
88 ZAR-28/Mar/97-03Ecklonia biminciata B WG-EXT-1 1500-2 meters South Aftrica
89 VSS-7/Feb/97-03 Padinagymnopora B WG-EXT-1 1853 meters Fiji
90 PNVB-6/Sep/98-05Lobophora B WG-EXT-122610 meters Papa New Guinea
Legend
BG = blue-green
R = red
G = green
B = brown43
Molluscicidal Screen; Algal Divisions
Red RIti-(Zrcpn .i Blue-Green
Brown
Green
DRed
Figure II.7.a. The taxonomic distribution of algal extracts represented in the
molluscicidal screening assay.
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Figure II.7.b The molluscicidal activity of algal crude extractsat 50 ppm..Overall, 46% of tested extracts caused molluscan lethalityat 100 ppm, and
34% were toxic at 50 ppm (Figure II.7.b). Figure 11.8 describes theoverall percentage
of molluscicidal activity of each of the divisions. The cyanobacteriadisplayed the
highest percentage of active extracts, with 58% and 46% of their memberstoxic at 100
and 50 ppm, respectively (Figure 11.9). Strong toxicitywas also observed in extracts of
Chlorophytes (56% at 100 ppm and 44% at 50ppm; Figure 11.10) and extracts of the
Rhodophyta (45% at 100 ppm and 29% at 50 ppm; Figure 11.11).Phaeophyceans
were responsible for the least molluscicidal extracts, with only I in 8 being toxicat
either concentration (Figure 11.12).
The lack of activity in the brown algal extractsmay be partially due to the small
sample size examined. It is also possible that, while lacking statisticalrelevance, the
low percentage of molluscicidal extracts for this division,as wells the high activity
rates observed for other divisions, reflects divergent methods of predator defense. It
has been theorized that algae can prevent predation ina number of ways, among them
chemical, structural (calcification), and photosynthetic (growth). The primarytenet of
this theory is the optimal allocation of resources by the algaeto those methods of
defense that will yield the highest probability of survival. Algae which optimizetheir
photosynthetic capacity, and thus grow in a rapid manner, and also oftento large sizes,
are able to avoid being decimated by predators by outgrowing them (suchas some
brown algae). Those that grow more slowly are believedto protect themselves by
producing a tough exterior (calcified red and green algae, for example)or by being
chemically defended (cyanobacteria, green and red algae).45
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Figure 11.8. Division breakdown of molluscicidal extractsat 100 and 50 ppm.46
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Figure 11.9. Molluscicidal Cyanobacteria Crude Extractsat 100 and 50 ppm.
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Figure 11.10. Molluscidal Chiorophyte crudeextracts at 100 and 50 ppm.47
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Figure 11.11. Molluscicidal iThodophyte crudeextracts at 100 and 50 ppm.
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Figure 11.12. Molluscicidal Phaeophyte crudeextracts at 100 and 50 ppm.48
The results of this survey support the hypothesis that marine algae produce
secondary metabolites that are toxic to snails, including freshwater representatives.
Further investigation is required to definitively link B. glabrata toxicityto compounds
that function in nature to protect algae from their natural molluscan predators. It is
reasonable, however, that such a correlation exists.
As an additional observation, the high potency of molluscicidal marine algal
extracts suggests that the 50 ppm test concentration may prove more efficient in initial
assessments of activity. Typically, a concentration of 100 ppm is used to identify
extracts worthy of further pursuit. However, the observed 34% lethality of extracts at
50 ppm provides a more restrictive, and therefore, more appealing threshold than the
46% observed when algal samples are tested at 100 ppm.
THE CHEMICAL INVESTIGATION OF PROMISING M0LLuscIcIDAL ALGAL EXTRACTS
The robust activity of marine algal extracts in the molluscicidal screening assay
afforded many candidates for further investigation. Of these, three were identifiedas
possessing the greatest promise of successful isolation of the molluscidical constituent,
a Fijian Portieria hornemanni (Rhodophyta) and two Malagasy Ljvngbja majuscula extracts
(cyanobacteria).
Remarkable molluscicidal activity was observed when an extract of P.
hornemanni was examined. While the typical molluscicidal assay is run for 24 hr, the
extract of P. hornemanni was 100% lethal to snails within 0.5 hr at 100, 50, and 25 ppm.
Full toxicity was also observed at 10 and I ppm, but only at the 24 hr time-point. The49
potency at the upper three concentrations resulted in the expulsion of hemolymph
(snail blood) by the snail into the water. This bleeding commenced priorto snail death
and continued briefly afterwards.
Guided by biological activity (at 25 ppm), the extractwas subjected to
successive rounds of chromatography utilizing VLC and solid phase extraction,and
final purification through HPLC (Figure 11.13). All of the molluscicidal activityof this
extract was due to a single non-polar major compound. Using the standard
assortment of spectroscopic experiments, the molluscicidal compoundwas identified
as the known metabolite chondrocole C (31, discussed further in Chapter III of this
thesis).6°Interestingly, chondrocole C retained the extremepotency of its crude
extract at 100, 50, and 25 ppm, but was non-lethal at concentrations below 25ppm,
yielding fully live snails after 24 hr. Despite this apparent lack of activity after 24 hr,at
10 ppm 31 caused the exuding of hemolymph during hourone. While this
observation coincided with rapid snail death when assaying the crudeextract and
active fractions, nearly full recovery of the snails could be observedat the end of the
first hour when 31 was tested. Possible explanations for the lack of concentration of
activity, as compared to the crude extract, include increased degradation of 31 inpure
form when exposed to the assay environment or multiple compounds acting
synergistically. Both of these conclusions are tenable, as 31 is acid sensitive and only
one of numerous compounds present in this extract that are structurally, and perhaps
toxicologically, similar (see Chapter III).
Molluscicidal activity (full lethality at 1-100 ppm) was also observed ina pair of
Malagasy L majuscula crude extracts. In one, collected off Nosy Tanikely, Madagascar50
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Figure 11.13. The isolation of the molluscicide chondrocole C (31).
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Figure 11.14. The isolation of the molluscicide tanikolide (32).51
(and referred to herein as Extract-MN'T), bioassay guided fractionation leadto the
isolation and structure elucidation of tanikolide (32, Figure II.14).61 Tanikolide,
however, only accounted for a portion of the toxicity observed in the crudeextract,
with an LD of 9 ppm compared to the full toxicity at Ippm of its parent extract.
Continued examination of the fractions of Extract-MNT for the remainder of its
molluscicidal activity resulted in the isolation of a second toxic compound,a lyngbic
acid(33)62While toxicity to brine shrimp has been observed previously for 33,
molluscicidal activity was unknown.62 Lyngbic acids arecomponents of the tail of the
non-molluscicidal malyngamides, the most frequently encountered ofLyzgbya spp.
secondary metabolites (Chapter IV). To validate the molluscicidal activity of 33, three
previously, and independently, isolated samples of 33, and the Extract-MNT 33,were
tested in the same assay. However, the results of this assay createdmore questions
than answers. While three of the samples, including 33 derived from Extract-MNT,
were lethal toB. gIabrata,one was completely inactive. Comparisons of 1-D 1H NMR
spectra could not define a single characteristic that would distinguish them from each
other, and the result remained a curiosity until the molluscicidal component of another
Malagasy L majuscula (Extract-MNA) was defined, as described below.
Extract-MNA was toxic to snails at concentrations as low as 0.1 ppm,a highly
robust activity for a crude extract. After each chromatographic step the biological
activity appeared to coincide with a somewhat polar and minor compound presenting
a 'lemon-yellow' char when treated with beat andH2SO4on TLC (Figure 11.15).
Fractionation was also concentrating the molluscicidal activity; final purification
yielded a compound that was fully lethal at an astoundingly potent 0.004ppm. The52
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Figure 11.15. Graphical representation of 20 on TLC.53
activity quickly decreased at lower concentrations, withanLD50established at 0.003
ppm and no activity at 0.002 ppm, after a 24 hr incubation.
Familiar resonances in the 1-D 'H NMR spectra suggested that the
molluscicidal compound of Extract-MNAwas the knownLmajuscula metabolite,
debromoaplysiatoxin (20, Figure 11.16), a fact confirmed by HPLC co-injectionwith a
standard solution of 20.63 As mentioned above, debromoaplysiatoxin hasa relatively
conspicuous polarity and charring pattern on TLC. The polarityrange coincides very
closely with lyngbic acid. In extracts with onlya minor component of
debromoaplysiatoxin, it is conceivable that the tailing char ofa fatty acid such as 33
could obscure the visualization of 20. HPLC co-injections confirmed this,with 20
present as an extremely minor contaminant of the lyngbic acid preparation of Extract-
MNT as well as the other two samples of lyngbic acid that displayed molluscicidal
activity. Consistent with this scenario, 20was not present in the lyngbic acid
preparation that was inactive against B. glabrata. The potency of 20accounts for most
of the activity of Extract-MNT, thus providinga satisfying conclusion to the
anomalous results that were encountered.
Debromoaplysiatoxin, one of the best knownLmajuscula metabolites, is
commercially valuable as a molecular probe due to its abilityto activate the protein
kinase C (PKC) pathway.Functioning in a manner similar to a phorbol ester, the
ability of 20 to stimulate the PKC pathway can lead to the promotion oftumors. In
order to determine if PKC pathway stimulation by 20 was thecause of its
molluscicidal activity, a series of whole animal pharmacological experimentswas
undertaken.54
Ljngbyamajuscuhr, Madagascar
VLC; EtOAC/Hexanes
HPLC; MeOH/H20
OCH3O
Lyngbic acid(33)
Inactive
OHL)ebromoaplyslatoxinOH
LD50= 0.003 ppm
Figure 11.16 The isolation of the molluscicide debromoaplysiatoxin (20) and the
inactive lyngbic acid (33).
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Phorbol 12-Myristate 13-Acetate(34, PMA)55
An assessment of the relative molluscicidal potencies of debromoaplysiatoxin
and the phorbol ester, phorbol 12-myristate 13-acetate (34) showed
debromoaplysiatoxin to be 80x more potent, with anLD50of 5.0 nM as compared to
400 nM for 34 (Figure 11.17). To determine the involvement of the PKC pathway in
the toxicity exhibited by 20 and 34 against snails, theywere assayed in the presence of
the PKC pathway inhibitor, MPKCPI (myrisoylated protein kinase C peptide
inhibitor). The molluscicidal assay was run as before but with the addition ofa 2 hr
pre-incubation period of the antagonist. The antagonistwas added at two
concentrations, equimolar and 2x molar excess, according to theLD50of the PKC
activator being tested. After the 2 hr incubation, the test sample was added and the 24
hr test period initiated. As a control, the inhibitor was tested and foundto possess no
molluscicidal activity.
As expected, the inhibition of the PKC pathway abrogated the molluscicidal
effects of PMA at both concentrations (Figure 11.18). However, whilenot dead, the
snails were visibly effected. When antagoni2ing the molluscicidal effects of
debromoaplysiatoxin, the inhibitor had only mixed success. Successful at inhibiting
toxicity at 10 nM (twice the LD of 20), at equimolar concentrations (5 nM),
debromoaplysiatoxin retained its lethality to the snails despite the presence of the PKC
inhibitor (Figure 11.18). Therefore, the molluscicidal activity of debromoaplysiatoxin,
and 34, is most likely due to their activity as PKC activators. The residual activity of
debromoaplysiatoxin in the presence of the PKC antagonist, and the decreased health
of the snails even in the presence of the antagonist, may hint at additional mechanisms56
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Figure 11.17. Molluscidal Activity of debromoaplysiatoxin (20) andPME (34).
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of molluscicidal activity, such as the potential fora different binding site or target.
The tropical plantJatropha curas(Euphorbiacieae) has also been shown to produce
metabolites which function as phorbol esters andmolluscicides.65Perhaps this
apparent snail sensitivity to PKC pathway activation could be exploited in the creation
of new molluscicides.
Despite the fact that debromoaplysiatoxin isa tumor promoter, it could still be
valuable in controlling the spread of schistosomiasis,as it has a few advantages over
niclosamide. The first advantage is potency; niclosaniide is fully lethalto snails in 2 hr
at 1.5mg/L,9or 4.6j.LM,whereas debromoaplysiatoxin is equally active in less than1
hr at the same molarity and 50% toxic at 1.6 .tM in 2 hr (Figure 11.19).Also, a
difficulty in working with debromoaplysiatoxin in the laboratory is itspropensity to
degrade, especially in the presence of acid. Thismay be a benefit if used as a
molluscicidal. While niclosamide accumulates in the soils, debromoaplysiatoxinwill be
degraded relatively quickly by microbial esterases. Resistanceto niclosamide has also
been noted inBu/inus truncatusin the field and laboratory samples ofBiomp ha/aria
labrata.; hence, a fundamentally new agent would be of value.
The utility of a compound such as debromoaplysiatoxin would be best in
artificial waterways such as rice paddies and irrigation channels wherea stable and
natural ecosystem would not be decimated. Taking advantage of the rapid action and
degradation of 20, a waterway could be inoculated periodically, presumably without
risk to human or livestock (assuming time is allowed for 20to degrade). Used in such
a manner, debromoaplysiatoxin or one of its pharmaceutical derivatives could greatly
assist in the effort to control the spread of schistosomiasis.EXPERIMENTAL
GENERAL
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NMR spectra were recorded on Bruker DRX 300 MHz spectrometer. Massspectra
were recorded on a Kratos MS5OTC mass spectrometer. UV spectra were recorded
on a Hewlett Packard 8452A diode array spectrophotometer while FT-JR spectra were
recorded on a Nicolet 510 spectrophotometer. HPLC separationwas accomplished
with a Waters M-6000A pump, a Rheodyne 7010 injector, anda Waters Lambda-Max
480 spectrophotometer or a Waters RI detector. Optical rotationmeasurements were
recorded on a Perkin-Elmer Model 141 polarimeter. Phorbol 12-Myristate 13-Acetate
(34, PMA) GAS 16561-29-8. FisherBiotech Cat. #BP685-1. Myristoylated Protein
Kinase C Peptide Inhibitor (MPKCT) Promega Corporation Cat. #V5691. Authentic
debromoaplysiatoxin source supplied by Dr. Kerry McPhail, OSU.
BIOLOGICAL MATERIAL
The marine red alga, Portieria hornemanni, was collected by hand from shallow
water (2-3 m) on 6 February 1997 at Taveuni Island, Fiji, and stored at 20°C in IPA
until workup. Original collections were made by G. Hooper and M. Graber. A
voucher sample is available from WHG as collection number VTI-6 FEB 97-1.
The marine cyanobacterium, Iyngbyi majuscula, was collected by hand from
shallow water (6-7 m) on 6 Apri, 1997 at Nosy Tanikely, Madagascar, and stored at-
20°C in IPA until workup. Original collections were made by W. Gerwick, G.60
Hooper, and E. Gerwick. A voucher sample is available from WHGas collection
number MNT-6 APR 97-1.
The marine cyanobacterium,Lngbjamajkscula, was collected by hand from
shallow water (1-3 m) on 5 April 1997 at Nosy Be, Madagascar and storedat 20°C in
IPA until workup. Original collections were made by W. Gerwick, G. Hooper, andE.
Gerwick. A voucher sample is available from WHGas collection number MNA-5
APR 97-1.
EXTRACTION AND ISOLATION OF CHONDROCOLE C (31)
The IPA preserved alga was extracted with CH2Cl2/MeOH (2:1)two times to
give a crude extract of 1.5 g. A portion of this (1.3g was fractionated using vacuum
liquid chromatography (VLC) on Si gel with a stepwise gradient of hexanes/EtOAc
and EtOAc/MeOH to give six fractions. Because fraction two (eluted 0%-10%
hexanes/EtOAc) possessed toxicity to B. glabrata (at 25 ppm), itwas subjected to RP-
Solid Phase Extraction (5mm Varian SEP Cartridge) witha 60-100% MeOH/H20
gradient. Molluscicidal activity was observed in fraction two (60-70% MeOH/H20),
which subsequently yielded pure 31 through repetitive NP-HPLC (90%
hexanes/EtOAc; 246 x 4.6 mm, 10j2Phenomonex Si Column, 1.5 mL/min) by the
collection of a peak centered at t = 6.3 mm detected by UV absorptionat 254 nm
(354 mg, 27% of total extract).61
EXTRACTION AND ISOLATION OF TANIKOLIDE (32)
The IPA preserved alga was extracted with CH2C12/MeOH (2:1)two times to
give a crude extract of 9.4 g. A portion of this (8.6 g) was fractionated usingvacuum
liquid chromatography (VLC) on Si gel with a stepwise gradient of
hexanes/EtOAc/MeOH to give eleven fractions. Fraction four (eluted 50%
EtOAc/hexanes), containing molluscicidal activity,was further subjected to VLC
(CHCJ2/MeOH) and collected as six fractions. Fraction 3, the molluscicidal fraction
in this series, was purified by HPLC (Versapak SilO .t, 300 x 4.1 mm, 1 mL/min, RI
detection, hexanes/EtOAc/IPA, 80:15:5) to yield 70 mg (8.1% of total extract) of
tanikolide by collection of a peak centered attR= 22 mm.
EXTRACTION AND ISOLATION OF DEBROMOAPLYSL&TOXIN (20)
The IPA preserved alga was extracted with CH2C12/MeOH (2:1)two times to
give a crude extract of 2.3 g. A portion of this (1.8 g) was fractionated usingvacuum
liquid chromatography (\TLC) on Si gel with a stepwise gradient of hexanes/EtOAc
and EtOAc/MeOH to give eight fractions. Because fractions six andseven (eluted
with 60%-100% hexanes/EtOAc) both contained 20, they were recombined and
subjected to semi-preparative RP-HPLC (Phenomonex Sphericlone ODS Column,
246 x 10 mm, 5 .t) in 90% MeOH/H20. Final purification (= 26 mm, 0.8 mL/min)
was accomplished using RP-HPLC (Phenomonex Sphericlone ODS Column, 246
4.6, 5 p) in 70% MeOH/H20 to yield pure 20 (1.3 mg, 0.O7% of total extract).62
M0LLuscIcIDAL BIOASSAY
Evaluation for molluscicidal activity was performed as previously described,
using Biomphalariaglabrata as the testorganism.25Aliquots of a 10 mg/nil (in EtOH)
stock solution of were serially diluted using EtOH to achievea range of
concentrations to be tested. To a 20 ml scintillation vial containing 9900 .i1 of ddH2O
100 pJ of test solution was added and the contents swirled. To each vialtwo snails
were added (approx. 8 mm each in diameter). After 24 hr the live and dead snails were
tallied. Snails were determined alive by visual observation of a heartbeator a response
to foot probing.
INHIBITION OF THE PKC PATHWAY
To eventually yield equimolar and 2x molar equivalents of the putative PKC
activator, the appropriate quantity of MPKCI (PKC antagonist) was dissolved in
EtOH. Into a 20 ml scintillation vial containing 9800 p1 ddH2O, 100 p1 of antagonist
was added. To this solution, two snails (as in the standard protocol) were added.
After a 2 hr pre-incubation period, 100 p1 of test solution (putative activator)was
added, and the assay was allowed to proceed in the standard manner for 24 hr. A total
of five replicates for each solution were tested.63
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CI-IAPmR III.
HALOGENAThD MONOTERPENES ISOLATED FROM THE FIJIAN RED ALGA
PORTIEPJA HORNEMANNI
4lT:Ii
Toxicity to the fresh-water snail, Biomphalariaglabrata, led to the re-
isolation of the biologically active halogenated monoterpene, chondrocole C,
from a Fijian collection of Portieria homemanni. Further investigation of this
extract allowed the isolation and identification of four additional halogenated
monoterpenes, all lacking molluscicidal activity.Literature searches revealed
all but one of the discovered secondary metabolites to have been previously
described. The isolation of these metabolites, including the newly discovered
taviochtodene, was carried out by preparative liquid chromatography with final
purification through repetitive HPLC. Structure elucidation was accomplished
utilizing 1D and 2D NMR spectroscopic characterization of the natural
products and comparisons with related halogenated monoterpenes. The
interpretation of anomalous heteronuclear connectivities, observed within the
NMR data acquired with chondrocole C, revealed the necessity for a minor
chemical shift re-assignment of chondrocole C.66
INTRODUCTION
Red algae, the Rhodophyta, are among themost frequently investigated
sources for marine natural products. This is primarily due to their
predominance in temperate and tropical locations wheremost collections
occur. A second contributing factor to their popularity for study is that there
are approximately 4000 species of red algae, more than the sum of all other
algalspecies.13'33Certain members of this division are commercially and
pharmaceutically important as producers of important phycocolloids suchas
carrageenan and agar, which are used in cough syrup, anticoagulants, laxatives,
and dentalmolds."26However, the red algae are also well known for their
prolific production of halogenated secondary metabolites, most oftenterpenes
containing chlorine, bromine, and iodine. The Plocamiaceae and
Rhizophyllidaceae families, which includeLaurencia, Ph7camium,Portieria, and
Ocbtodes spp., are particularly adept in utilizing this relativelyrare biosynthetic
pathway.67'68The numerous structures elaborated by these familiescan be
categorized into four predominant skeletal arrangements (Figure 111.1), 1-ethyl-
3,3-dimethylcyclohexanes (ochtodanes), 1 -ethyl-2,4-dimethylcyclohexanes, 1-
ethyl-i ,3-dimethylcyclohexanes, and2,6-dimethyloctanes.69The Ochtodes and
Portieria spp. are prolific producers of the ochtodane (Figure 111.2) and
dimethyloctane (Figure 111.3) groups, as well as the closely related
chondrocoles (Figure 111.4).
Rather than specializing in the production of any single member of
these groups, the producers of halogenated terpenes have displayeda high67
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Figure 111.1. The four major skeletal arrangements isolated from
PortienaandOchtodes spp./
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Figure 111.5. Mass spectral isotope cluster patterns observed for
halogenated compounds.71
degree of chemical variability, producing suites of related compounds thatvary
in composition of individual examples and in the proportion of acydicvs.
cyclicmetabolites.71Geographic, or site-to-site, variability of secondary
metabolites has also been observed for these families, at times from samples
separated by less than 10miles.71'73'78'79Accepting the available evidence that
these suites of compounds confer chemical protection upon their producers, it
would seem that the elaboration of numerous modestly active secondary
metabolites is energetically less efficient than the production ofa single highly
potentmetabolite.68'71However, a current theory concerning the evolution of
secondary metabolites suggests that this is a sort of 'bet-hedging'approach.8°
In this manner the producer of a chemical defense distributes its resources
widely, protecting itself against the adaptability of thetarget.8°
Paul et al., while describing halogenated monoterpenes isolated from a
Galapagos Ocbtodescrockeri,discovered feeding deterrence (to fish) in each
compound at the 100 ppm level(46-48, 60, 6264).68Despite the immediate
presence of local herbivores, such as marine iguanas, Ochtodes grows luxuriantly
and seemingly withoutpredation.68While further, ecologically relevant,
investigation is necessary to prove such defensive utility for these compounds
in nature, the evidence is compelling, especially considering the predatory
pressure in their local environment and the observation that these metabolites
collectively comprise approximately 15,000 ppm of the alga's dryweight.68
While such discoveries of biologically active red algal secondary
metabolites provide exciting reasons to study the Rhodophyta, the finding of a72
potential antitumor red algal compound has further stimulated suchpursuits.72
Halomon (50), discovered from Portieria bornemanrn, exhibitedan antitumor
profile of high priority at the National Cancer Institutes(NCI).72In initial in
vivo studies, halomon has given rise to a 40% apparent cure rate against the
U251 brain tumor cell line (5 doses/day, 50mg/kg).72'73Despite such
promising results and selection for preclinical development, halomon hasnot
proceeded through the drug pipeline to the marketplace. Itsprogress has been
hindered by the small quantities found in natural collections andan inability to
synthesize the compoundefficiently.72'73In fact, balomon has only been found
on three occasions; as a mixture from a 1975 Hawaiian sample, the original
Chanaryan collection (Philipines), and a 1992 re-collection at Chanaryan sites.
Attempts to reisolate 50 have led to the discovery of a number of related
halogenated monoterpenes, and provided a wealth of structure-activity data for
this drugclass.72'73
Isohalomon (51), 7-dechloro-6-dehydrohalomon (52), and its
brominated isomer (53) displayed the characteristic cytotoxicity profile of
halomon, with similarpotency.73Therefore, the presence or absence of a C-7
halogen, the type of halogenation at C-6, and the saturation state of the C6-C7
bond is not of critical importance foractivity.73However, the presence of a
halogen atom at C-6 is important, as 54 displayed only mild toxicity and
produced a profile that was not related to halomon or the other active
halomon-likecompounds.73Compounds 55-57 displayed similar profiles and
potency to 54, and were therefore also dissimilar tohalomon.73The73
importance of C-2 chlorination for full potency was thus proven as 2-
dechiorohalomon (55), differs from halomon only at this singleposition.73
The recollection efforts in search of halomon have not produced a
sustainable source of the potentialdrug.71'72'73In fact, they have yet to even
provide much additional material, with the exception of the 1992 Chanaryan
expedition.73However, the structure-activity data gleaned to date has begun to
define the active pharmacophore of halomon, and will be invaluable to any
future synthetic approaches. Further collection efforts will doubtlessly yield
more useful data as well as potentially provide the sought after store of
halomon, or an equally active analog.74
RESULTS AND DISCUSSION
Chosen as part of an effort to screen marine algae formolluscicidal activity
(Chapter Ii), the organic extract of a Fijian red alga, Portieria bornemanni,demonstrated
dramatic activity in this assay with snail death and hemolymphexpulsion occurring
within minutes at 25 ppm. While pursuing the isolation of the molluscicidalsecondary
metabolite of this alga, GC/MS and TLC analysis of inactive fractionsrevealed the
presence of a wealth of halogenated small molecules. P. hornemanni,a member of the
Rhizophyllidaceae family, is known to produce suites of halogenated
monoterpenes.6779
The screening of non-polar fractions of thisextract of P. bornemanni showed a
plethora of halogenated compounds, as recognized by characteristicisotope patterns
present in the mass spectrometry data (see Figure 111.5 for examples). Isotope
patterns were also used to make preliminary assessments of the types and number of
halogen atoms in these molecules, greatly facilitating the search for compoundsof
potential interest, such as those displaying unusual halogenation.
The phytochemical investigation of these fractions, guided by GC/MS and
TLC, resulted in the isolation of three compounds which have been previously
reported in the literature. For one of these, GC/MS analysis revealeda minor
compound possessing three bromines and a chlorineatom. Pursuing this metabolite,
HPLC isolation yielded the polyhalogenated ochtodene, 2-chloro-1,6 (.5),8- tribromo-
3-(8)(Z)-ochtodene (44b), as a minor metabolite. Previously isolated froma Caribbean
Ochiodes secundiramea,44bwas the first ochtodane found to possess a cyclic vinyl
halide.74360000
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Figure 111.6. GC/MS of chondrocole C.
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A second known and cyclic monoterpene was also isolated by HPLC froma
nonpolar fraction. Displaying a molecular weight by GC/MS of 264 da, withan
isotope pattern indicative of a single chlorine and bromine atom, this compoundwas
defined (through 1-D 1H NMR and GC/MS) to be chondrocole A (58)or its
diastereomer, chondrocole B (59). Chondrocoles A and Bwere originally isolated
from a Hawaiian Chondro coccus hornemanni (synonymous to P. hornemanni)
The third known compound discovered in this pursuitwas originally thought
to be a cyclic monoterpene similar to the chondrocoles or ochtodenes. This
assessment was made based on both GC/MS and NMR observations. However, key
correlations in the 2-D NMR data sets suggested this to bea linear molecule. The
most logical structure, that describing 2-dechlorohalomon, was confirmed by
comparisons of 1-D 1H and 13C NMR chemical shifts with published literature values.
This metabolite (55) is a close structural relative of halomon (50),a potential
anticancer drug that has proven difficult to obtain from either field collectionsor by
chemical synthesis.
Following the molluscicidal activity through successive tiers of
chromatography, the molluscicidal component was isolated as a UV-active non-polar
compound that was also the major metabolite of this extract (27%). GC/MS data
suggested that this compound had two bromine atoms and a molecular weight of 308
da (Figure 111.6). A molecular formula ofC10H14OBr2was deduced as an initial
starting point in the structure elucidation of 60. The components of this formula were
confirmed through 1-D 1H (Figure 111.7) and 13C NMR (Figure 111.8) experiments,9
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which displayed relatively simple spectra consisting of 10carbon and 14 proton
resonances. The only element remaining to be assigned from the molecular formula
was a single oxygen atom. A literature search, using the molecular formula, showed
that NMR values for chondrocole C matched those for this molluscicidalcompound.68
However, when the carbon and proton assignments from the literaturewere applied to
the molecule, and checked against the HMBC data (Figure 111.9)collected for the
molluscicidal agent, there was a disparity.
Figure 111.10 graphically describes the longrange NMR data collected for
chondrocole C using the literature values to anchor the placement of the 13CNMR
chemical shifts. Such an inordinate number of unusual couplingsin chondrocole C
raised questions concerning the reported structure of chondrocoleC. However, these
questions were fully answered upon closer inspection of the HSQC (Figure111.11)
data collected for 60. Originally unnoticed, the HSQC displayed 'Jcoupling from H-6
to C-8 and from H-8 to C-6 (using the literature values to assign chemical shifts). This
pinpointed the problem. Applying this re-assignment providesa much more palatable
combination of correlations (Figure 111.12). Such data miss-assignments in the
literature may exist in more than just this isolatedcase, as the resolving power of
modern NMR spectrometers, and the utility of recently developed pulsesequences,
allow more detailed spectroscopic investigations than in thepast.
A fifth non-polar and minor metabolite was also isolated from thisextract.
Analyzing for a molecular weight of 362 da, the isotope pattern appearedto be
produced two bromine and two chlorine atoms (Figure 111.13). The remainingmass
units could be accounted for by C10H14,a fact confirmed by HRCIMS (M at81
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Figure 111.10. Proposed long-range correlations for chondrocole C using
the chemical shift assignments as in the literature.75CC C
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361.8839;= -0.9 rnmu for C10H14Br2C17). The 1-D 1H NMR (Figure 111.14)
displayed a now familiar sample of peaks, including those for gem-dimethyl and
halomethine protons. Also present was a highly coupled down field signal (H-X)
representing an olefinic proton.
HSQC (Figure 111.15) allowed the appropriate assignment ofprotons to their
respective carbons (Table 111.1). The four halogens expected from the MS data could
be further assigned as being a trio of halomethines, CMX moieties (Xhalogen),
and a primary CH2X functionality, by characteristic chemical shifts. The HSQC data
confirmed the presence of a single protonated olefinic carbon, indicating that itwas
trisubstituted. This olefin accounted for one of the two degrees of unsaturation
described in the molecular formula. The remaining two carbons, whichwere the only
remaining elements of the molecular formula, were thereby definedas the olefinic
partner and the quaternary carbon completing the gem-dimethyl system.
HMBC (Figure 111.16) correlations, detailed graphically in Figure 111.17,
confirmed these assignments, as connectivities could be observed between thegem-
dimethyl protons (H3-9 and H3-10) and C-7 and from H-2 to the olefinic carbon C-3.
Also observed from H-2 was a correlation to the halogen bearing carbon, C-8.
Carbon 8 was further defined as being adjacent to the gem-dimethyl system because H-
8 showed connectivity to C-9. Carbon 9 displayed long range heteronuclear coupling
to another of the halomethines as witnessed by a correlation from (1-13-9 to C-6, as well
as to C-8, and a cross-peak from H-6 to C-9). Connectivities from the methylene H-5
protons to both C-6 and C-4 allowed placement of C-5 as being a part of a
halomethine-CH2-halomethine system. These correlations account for all of theppm
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Figure 111.17. Key HMBC correlations used to define taviochtodene (65).90
Table 111.1. NMR data for taviochtodene (65).
Carbon# '3C&
1 37.82 4.13 dddd (1.7, 7.5, 11.7, 15.0)
2 127.3 6.34 ddd (2.0, 7.5, 8.6)
3 138.18
4 54.92 5.17 dd (2.7, 4.0)
5 41.51 2.48 ddd (4.8, 12.8, 15.7)
2.56 ddd (2.6, 3.8, 14.6)
6 55.24 4.54 dd (4.4, 12.4)
7 45.30
8 59.88 5.05 bs
9 15.31 0.99 s
10 30.41 1.43 s
Recorded on Bruker DPX 300 (75 MHz) in CDCJ3.
bRecorded on Bruker DPX 300 (300 MHz) in CDC13.91
elements of the molecular formula; the sole exception beinga single degree of
unsaturation. This was provided by the logical ring closureat C-4-C-3, and confirmed
by an HMBC correlation from H-4 to C-3.
The proper placement of chlorine and bromineatoms was attempted
following chemical shift rationale using the representatives of the ochtodeneand
chondrocole structure classes (Figure 111.2 and 4)as evidence. Figure 111.18 allows
comparison of the 1H and 13C NMR shifts observed for ochtodenesand chondrocoles
most closely resembling the new ochtodene, taviochtodene (65). Most compelling is
the similarity between the gem-dimethyl moieties of chondrocole C andtaviochtodene.
In most of the ochtodenes and chondrocoles, less than 10ppm separates the peaks of
C-9 and C-10. But C-9 and C-b, in chondrocole C and 65,are separated by 14.9 and
13.1 ppm, respectively. Also, 60 and 65 are the only presented examples thatdisplay a
C-9 chemical shift which approaches 15 ppm. This observationsuggests that both
bromines are in the same plane for 65, and attached at C-6 andC-8.67Chemically, the
diequatorial positioning of large groups suchas bromines is more logical. Of
particular note, chondrocole C is the lone representative of these structural classes
whose gem-dimethyl pair is flanked by two bromine bearing carbons, andwas also the
major component of this extract. The bromines being placedupon carbons 6 and 8,
the chlorides were logically located at C-4 and C-i. Thus the planarstructure of
taviochtodene was elucidated. Attempts were made to investigate the Bor Z
stereochemistry of the C2-C3 double bond using the HSQMBC, NOESY, and
DPFGSE NOE pulse sequences. No data could be gleaned fromany of these
experiments, but, presumably due to the limitations of sample size (all other NMR92
Table 111.2. Chemical shift comparisons of selected ochtodenes and chondrocoles,
compound numbers in bold at column tops (aaxial, eequatothal).Chemical
shifts reversed in literature. bNMR run inC6D6as opposed toCDCI3.
35 37 38 42 45 58 60 61 65
C-I 37.6 37.3737.6237.6 39.6 75.3 75.3 171.037.82
C-2 131.9131.67131.89131.8125.0124.8124.8115.4127.3
C-3 137.7138.22137.83137.9 137.6138.3164.4138.18
C-4 50.4 59.5850.4450.473.6 80.7 82.6 76.9 54.92
C-5 41.3241.8041.3241.342.6 41.7 41.4 40.0 41.51
C-6 52.7052.7252.7052.7 54.9 54.4 557il51.0 55.24
C-7 41.3241.0341.3641.4 41.743.6 42.3 45.30
C-8 70.0 60.6569.9870.0 68.8 63.8 54.8
a60.8 59.88
C-9 20.420.6320.4720.5a21.5 21.0 16.0 20.5 15.31
C-b 28.528.6028.5328.5a26.6 27.6 29.1 26.9 30.41
35 37 38 42 45b 58 60 61 65
H-i 4.05
4.20
4.02
4.16
4.04
4.18
4.04
4.18
4.3 4.724.66 - 4.13
H-2 5.966.03 5.95 5.95 5.30 6.975.90 6.97 6.34
H-3 -
H-4 4.99 e4.65 4.97 4.97 4.47 4.78 4.60 - 5.17
H-5 2.55
2.71
2.50
2.65
2.53
2.68
2.53
2.67
1.86
1.92
1.95 a
2.94 e
2.10 a
2.60 e
1.95 a
2.94 e
2.48
2.56
H-6 4.85 a4.83 4.83 4.84 4.17 4.404.00 4.40 4.54
H-7
H-8 4.404.73 4.38 4.38 3.85 4.65 4.46 4.78 5.05
H-9 1.03 1.02 1.01 1.01 0.78 1.07 1.09 1.07 0.99
H-b 1.30 1.33 1.28 1.29 1.0 1.32 1.36 1.32 1.4393
experiments were accomplished at a much earlierstage, before experiments destructive
to the compound were undertaken). However, an examination of the coupling
constants of H-5 of35[2.55 (ddd, 4.8, 12.5, 15 Hz), 2.71 (ddd, 1.8, 4.5, 15)],37[2.50
(ddd, 2.4, 4.6, 15.0), 2.65 (ddd, 2.4, 12.4, 15.0)],38[2.53 (ddd, 5.0, 12.7, 15.3), 2.68
(ddd, 1.8, 4.1, 15.1)], and65[2.48 (ddd, 4.8, 12.8, 15.7), 2.64 (ddd, 2.56, 3.8, 14.6)] is
potentially enlightening concerning two aspects of taviochtodene'sstereochemistry,
the relative stereochemistry of C-4 and C-6 and the orientation of theC2-C3 olefin.
The chemical shifts of the H-5 pair in all of these examplesare nearly identical,
suggesting similar chemical environments and further supporting theplacement of
halogens in65. Asthe structures of35and37are the same except for a substitution
of chlorine for bromine as the primary halogen in37.And, because37and38are
geometrical stereoisomers differing only in the orientation of the C2-C3olefin (35 and
37share the same geometry of this moiety) the noted couplingconstant differences
witnessed between35/37and38can be reasoned to be due to this altered geometry.
'While this is somewhat unexpected, and may suggest stereochemicalmis-assignment
in38,the structure of38 issupported by X-Ray crystallography. As such,65 displays
nearly identical H-5 coupling constants to those of 35 and37.Therefore, despite the
lack of acquired data to explain these features of 65 it is possibleto tentatively assign
them as depicted, with an B C2-C3 olefin, equatorial H-4, and axial H-6. This analysis
is further supported by analyzing the coupling constants H-4,5,6 of65without use of
the model compounds. With65drawn in a pseudo-boat structure it becomes clear
that the positioning of H-4 as equatorial will yield two small couplingsto the protons
of H-5, which is what is observed experimentally (Table 111.1). Likewise, foran axial94
H-6, one small and one large coupling should be observed,as can also be seen in
Table 111.1. As stated above, the C-8 brominewas expected, through chemical shift
rationale, to be in the same plane as the C-.6 bromine, thus suggestingthe assignment
of H-8 as axial.
Similar to previous reports of the secondary metabolitecomponents of the
Rhizophyffidaceae, the extract investigated herein produceda suite of related
halogenatedmonoterpenes.6779In addition to the presented metabolites, GC/MS
analyses of this extract suggested the existence ofa number of further examples of
these same structural classes present, however,as extremely minor components. It is
hypothesized that these compounds provide chemical defense againstpredation.68
The previous biological activity associated with thesestructure classes, and the
observed molluscicidal activity for chondrocole C,appear to support this hypothesis.
The isolation of 2-dechiorohalomon from a Fijian P.hornemanniprovides a potential
new territory in which to explore for the elusive anticancer compound, halomon, and
its biologically active derivatives.
The utility of GC/MS analysis in the isolation andstructure elucidation of
halogenated monoterpenes cannot be overemphasized. During the GC/MS analysis
of this extract an empirical observation was made concerning the isotopepatterns of
polyhalogenated metabolites. The labile nature of halogens under GC/MS conditions
can result in their loss in the ionization chamber. In such an instance, analyzing the
data could lead to an incomplete understanding of the molecule interms of molecular
weight and halogen content. However, for molecules thatpossess at least one
bromine and chlorine pair, this potential problem can beovercome.95
First, identify the two fragment peaks that represent the highestmasses and subtract
their molecular weights from each other. A difference of 44mass units [also equal to
79 (Br) minus 35 (Cl)] suggests the loss, prior to mass detection, ofa bromine atom.
Likewise, a difference of 45 mass units is indicative of a loss of HBr.
Figure 111.19 presents this observation using a hypothetical compound withan
unknown molecular weight. GC/MS analysis of this molecule reveals two major
fragment peaks, 179 and 135 mu. The 179 mu peak has an isotopepattern indicative
of a single chlorine atom, while the 135 mu peak suggests a single bromineatom. The
difference between these two peaks is equal to 44 mass units. Now add 35to the 179
mu peak (the highest molecular weight peak) to arrive at the true molecular weight of
the compound, 214 mu. From this molecular weight a loss of Br (79 mu) would result
in the detection of a 135 mu peak, by GC/MS. The 179 mu peak represents the loss
of chlorine (35 mu). Thus, the halogen content suggested by the isotope patterns and
the fragmentation pathways to the fragment peaks are logical, and supported by the
data.
More complex situations, such as the loss of multiple halogen atoms, can also
be understood by the application of this method. The use of this empirical tool can
help to deconvolute what are often complex chromatograms filled with useful
structural information.96
GC/MS Fragment Peaks
135
- 44
179
I
Br79
- Cl=35
44
179
+Cl Hypothetical compound must have at least one
216 more halogen. In this instance, m/ = 216.
135 +Br79
Figure 111.19. Hypothetical compound (m/ = 216) demonstrating the empirical
observations that, in GC/MS, structural data can be obtained for halogenated
compounds even when the halogen is too labile for mass spectral detection.97
EXPERIMENTAL
GENERAL
NMR spectra were recorded on Bruker DRX 600 and DPX 300 MHz
spectrometers. Mass spectra were recorded on a Kratos MS5OTC mass spectrometer.
UV spectra were recorded on a Hewlett Packard 8452A diode array
spectrophotometer while FT-IR spectra were recorded on a Nicolet 510
spectrophotometer. GC/MS analysis was accomplished on a Hewlett Packard Gas
Chromatograph 5890 Series II Gas Chromatograph with a Hewlett Packard 5971 Mass
Selective Detector using an HP-I capillary column. HPLC separation was
accomplished with a Waters M-6000A pump, a Rheodyne 7010 injector, and a Waters
Lambda-Max 480 spectrophotometer. Optical rotation measurements were recorded
on a Perkin-Elmer Model 252 polarimeter.
BIoLoGIcAL MATERIAL
The marine red alga, Portieria hornemanni, was collected by hand from shallow
water (2-3 m) on 6 April, 1997 at Viti Taveuni, Fiji and stored at 20°C in IPA until
workup. The original collection was made by G. Hooper and M. Graber, and a
voucher sample is available from WHG as collection number VTI-6 APR 97-1.
EXTRACTION AND ISOLATIONOFCHONDROCOLE C (60) AND TAVTOCHTODENE (65)
The IPA preserved alga was extracted with CH2C12/MeOH (2:1) two times to
give a crude extract of 1.5 g. A portion of this (1.3 g) was fractionated using vacuum98
liquid chromatography (VLC) on Si gel witha stepwise gradient of hexanes/EtOAc
and EtOAc/MeOH to give six fractions. Because fractiontwo (eluted 5%-IO%
hexanes/EtOAc) possessed biological activity to B.glabrata,it was subjected to RP-
Solid Phase Extraction (5mm Varian SEP Cartridge) witha 60-100% MeOH/H20
gradient. Molluscicidal activity was observed in fraction 2 (60-70% MeOH/H20),
which subsequently yielded pure 60 through repetitive NP-HPLC (90%
hexanes/EtOAc; 246 x 4.6 mm 10 t Phenomonex Si Column, 1 rril/min) by the
collection of a peak centered at'R= 6.3 mm detected by UV absorption at 254 nm
(354 mg, 27% of total extract). Fraction 6 from the Solid Phase Extraction abovewas
subjected to preparative NP-HPLC (85% hexanes/EtOAc; 246x 10 mm 10.1
Phenomonex Si Column) in a phytochemical pursuit of additional halogenated
compounds. Further purification of one of the collected peaks (elution centeredattR
4.2 mm detected by UV absorption at 254 urn; 4.5 ml/min)was accomplished using
NP-HPLC (95% hexanes/EtOAc; 246 x 4.6 mm 10 x Phenomonex Si Column)to
yield essentially pure 65 (peak centered attR= 8.1 mm, 0.9 mi/mm, 0.3 mg, 0.002% of
total extract). Compounds 44b, 55, and 59 were purified from fractions of this series.
TAVIOCHTODENE(65)
Pure taviochtodene showed[a]250+35 (CHC13, c 0.1); UV &max (MeOH) 245
urn (log c = 5,000); JR vmax (film) 2964, 2860, 1380, 1365, 897 cm1; LRCIMS (0.1 M
oxalic acid/2:1 thioglycerol:glycerol) obs. m/ (rel int) 362 (10), 327 (75), 283 (100),
247 (50), 211 (15), 203 (25), 167 (45); HRCIMS (0.1 M oxalic acid/2:199
thioglycerol:glycerol) obs. [MJ m/361.8839 forC10H14Br2C12 (i0.9 mmu); 1H and
13C data see Table 111.1.
M0LLuscIcIDAL SCREENING PROTOCOL
Evaluation for molluscicidal activity was performed as previously described
using Biorirpha1aiaglabrata as the test organism. Aliquots of a 10 mg/nil (in EtOJ-l)
stock solution of 60 were serially diluted using EtOH to achievea range of
concentrations to be tested. To a 20 nil scintillation vial containing 9900 tl of ddH2O
100 .tl of test solution were added. To each vial two snails were added (approx. 8mm
each); after 24 hr the live and dead snails were tallied. Snails was determinedto be
alive by visual observation of a heartbeat or a response to foot probing. Fractions and
pure compounds were, at a minimum, tested in duplicate (in separate scintillation
vials).100
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CI-IAPmR IV.
ISOLATION AND STRUCTURE ELUCIDATION OF THREE NEW
MALYNGAMIDES FROM THE MARINE CYANOBACTERIUM,LYNGBYA
MAJUSCULA
ABSTRACT
A pair of lipid extracts ofLngba majuscula,one collected from Curaçao and
the other of Malagasy origination, have yielded malyngamides L (80, Curacao),Q, and
R (70 and 71, Madagascar). All three are amides of 7-methoxytetradec-4-enoic acid,
quite common among the malyngamide class of secondary metabolites. Malyngamide
L bears resemblance to the cyclohexyl-type subclass, while malyngamidesQ and R are
most closely related to malyngamide A, a pyrrolidone-type malyngamide. The
isolation of these metabolites was carried out by preparative liquid chromatography
with final purification through repetitive reversed phase HPLC. Structure elucidation
was accomplished utilizing 1D and 2D NMR spectroscopic characterization of the
natural products and comparisons with related malyngamides. DPFGSE NOE data
suggested different geometrical stereochemistry at C-6 in malyngamides Q and R from
that observed for other known malyngamides. The Z stereochemistry was confirmed
for malyngamide R by measurement of2.JCHcoupling utilizing the HSQMBC pulse
sequence. The absolute stereochemistry of C-4" of the pyrrolidone ring was defined
by chiral GC/MS analysis.102
INTRODUCTION
The malyngamides are the most pervasive class of L majuscula secondary
metabolites. Isolated from IL. majuscula of distinctly varied marine habitats, from
locations spanning the globe in tropical locations, 27 malyngamides havenow been
reported in the literature.8195 Of these, our laboratory has identified malyngamides F
(76),86 F-acetate (77),86 }I (86),88 I (78),89J (87),° K (75),90 L (8O),°Q (7O), R (71),
and S94 (92) from Caribbean, Indonesian, Fijian, Malagasy, and New Guinean L
tnajuscula, respectively. While malyngamides have also been reported fromsources
other than IL majuscula, these most likely represent collections includingLmajuscula,
and not de novo non-cyanobacterial biosynthesis.91
The frequency with which known and novel malyngamides are encountered
suggests a demonstrative energetic biosynthetic output by the alga, which often
denotes utility in nature. Discovering members of this structure class from diverse
habitats and divergent locations intimates an ancient genetic derivation. However,
only modest biological activity, pharmaceutical or chemical ecological, has been
demonstrated in the malyngamides to date. Regardless of the presence or absence of
substantial biological activity, the malyngamides represent a widespread (within theL
majuscula species) and structurally interesting series of marine natural product.
THE MALYNGAMIDE STRUCTURE
In all malyngamides, two molecular 'halves' can be observed, a methoxylated
fatty acid tail and an amino acid derived head. Four fatty acid chain lengths have been
identified thus far, C-12, -14, -16, and 20, with the vast majority of malyngamides103
having a 14 carbon chain. A high degree of fidelity can be seen in two aspects of the
fatty acid portion, with all known malyngamides possessing a C-4/C-5fransdouble
bond and a methoxy group at C-7. Malyngamides D (84) and E (85), the only
examples with a C-16 chain, are also the only with additional chain functionalization,
being methylated at the C-9 position.Collectively, the four malyngamide fatty acid
chain variants have been given the trivial name 'lyngbic acids' (FigureTV.1).33
A higher degree of variability can be seen in the malyngamide head groups
connected to the fatty acid chain by an amide bond. To date, five basic types of amide
portions have been discovered, pyrrolidone (Figure W.2), cyclohexyl (Figure IV.3),
non-chlorinated (Figure IV.4.A), acycic (Figure IV.4.B), and lactone (Figure IV.4.C).
The most commonly isolated malyngamides are of the cyclohexyl-type, followed by
the pyrrolidone and non-chlorinated types, and the recently discovered acydic and
lactone varieties.
Four motifs are typically seen in cyclohexyl malyngamides, a vinyl chloride
(Figure IV.5.A.1), a cyclohexyl ring system (Figure TV.5.A.2), an oxygen bearing C-5'
(Figure IV.5.A.3), and a C4'-C9' olefin or epoxide (Figure IV.5.A.4). The pyrrolidone
malyngamides are characterized by the vinyl chloride (Figure JV.5.B.1), a conjugated
enone system (Figure IV.5.B.2), and what appears to be a cyclized polyketide-extended
amino acid (Figure IV.5.B.3). The non-chlorinated malyngamides, obviously lacking
the vinyl chloride, possess either an exomethylene moiety adjacent to the cyclohexyl
ring (Figure IV.5.C.1) and an additional pre-ring methylene group (Figure IV.5.C.2) in
malyngamides H andJ, or have functionalizationato the nitrogen (I), E, and the
serinol-derived malyngamides; Figure IV.5.D.1).104
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Figure IV.5. Common structural motifs of malyngamide
amino portion.109
Structural trends cannot be established for the remaining malyngarnides, the
acycic and lactone types, due to the small number of each that have so far been
discovered. The two members of the acydic subclass of malyngarnidesappear to be
simple analogs of each other, closely resembling the main body of those of the
pyrrolidone group. Interestingly, the acycic and pyrrolidone subiclasses are the only
having members with altered geometric stereochemistry at the vinyl-chloride carbon,
as compared with other malyngamides.
CONSIDERENG MALYNGAMIDE BIoGENEsIs
While no biosynthetic experiments investigating the malyngamides have been
reported in the literature, the structural similarities and the ability to form 'family'
groupings allows for biogenetic speculation on the malyngamide head group. Similar
to the manner used above tosimplifythe discussion by subdividing the malynganiides
into groups, a biogenetic analysis also benefits from forming 'family' groupings.
Serine-derived malyngamides
Malyngamides D (84) and E (85), lacking a vinyl chloride and having a
functionalized a carbon and an unusual fatty acid tail, appear biogenetically unusual
next to most other malynganiides. The discovery of the serinol malyngamides has
added members to the list of non-standard malyngamides, and insight into the
biogenesis of the entire structure class. Figure IV.6.A is a biogenetic scheme leading
to the creation of 84 and 85 and the serinol derived malyngamides (90 & 91).110
Malyngamides D and E could be created by a series of three polyketide extensions
proceeding from the serine carboxyl, ultimately terminating in ring closure and
functionahzation.
Pyrrolidone malyngamides
The relationship between the pyrrolidone malyngamides and the acycic
malyngamides 0 (88) and P (89) is relatively obvious, with 88 merely terminating ina
methoxy moiety rather than the standard pyrrolidone ring system. Additionally, the Z
stereochemistry of the vinyl chloride olefin, as opposed to the B stereochemistry
present at the same position in other chlorinated malyngamides, can be seen in all but
malyngamides A (66) and B (67) of this group. The retained stereochemistry and the
presence of most discernable features of the more derivatized malyngamides may
suggest 66 and 67 being intermediates leading to the pyrrolidone malyngarnides
(Figure JV.6.B).
Cyclohexyl and non-chlorinated malynganiides
The two previously described groups, the serinols and the pyrrolidones, supply
key elements to speculation upon the biogenesis of the cyclohexyl malyngamides.
Firstly, viewing the substitution pattern of the typical cyclohexyl ring system brings an
immediate comparison to malyngamides 0 and P, but with what appears to bean
additional acetate unit. So, by extension, the as yet undiscovered parent of the
cyclohexyl malyngamides can be conceptualized in Figure IV.6.C.Acid Ta +Setin] w
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Figure IV.6. Malyngamide biogenesis.112
The theory put forth in Figure IV.6.A, with polyketide extension of serine
leading to the creation of 85 and 86 allows the possibility of a similar scenario for the
cyclohexyl malyngamides. The strongest amino acid candidate, considering the lack of
an amino side chain as evidence, would be glycine (Figure IV.6.C). Polyketide
extension and tailoring would produce the proposed precursor. Attack by the C-2 of
acetate, as scene in jamaicamide biosynthesis, would precede halogenation, leading to
the cyclohexylmalyngamides.96Glycine would also apparently be the starter unit for
polyketide extension in the pyrrolidone malyngamides as well. In parallel,
malyngamides H andJ, rather than utilizing glycine for polyketide extension, may
incorporate-alanine (Figure JV.6.D), by this analysis. The lack of chlorination in
these molecules may suggest some structural impediment to the halogenation
mechanism. Malyngamide S (92), the only malyngamide with a lactone ring, could be
the product of the proposed alternative cyclization pathway proposed in Figure
JV.6.C.113
RESULTS AND DISCUSSION
In an effort to discover and identify structurally intriguing and biologically
active secondary metabolites from marine algal sources, the crudeextracts of two
collections of Ljvngbja majuscula were investigated. The evaluation of NMR data, TLC
characteristics, and in-house biological activity assays has lead to the isolation of
malyngamides L (80), Q(70),and R(71).90'92Malyngamide L is a cyclohexyl
malyngamide derived from a Caribbean L majuscula, while70and71are pyrrolidone
malygamides of Malagasy origination. Modest biological activity has been observed in
both malyngamides L (brine shrimp and goldfish) and R (brine shrimp).
MALYNGAMIDE L
Malyngamide L (80) was isolated as an optically active oil([aJ25D= + 17°, c =
0.1, EtOH), of modest toxicity (Anemia sauna LD = 8.0 j.tg/ml, Carassius auratusLD50
= 15.0 j.tg/ml) from a Curaçaoan collection of Ljngbjva majuscula. LRFABMS revealed
a molecular ion of 468, with an isotope pattern descriptive of a single chlorine (Figure
IV.7). HREIMS analysis of 80 described a molecular formula, (C26H42NO4C1; JjM-Cl]
at m/ 432.3096,1.7 mmu), suggestive of six degrees of unsaturation. Through the
interpretation of 1D and 2D NMR data sets (Figures IV.8-1 1), a trio of substructures
were compiled clearly reflecting some commonly observed motifs of the
malyngamides (Figure IV.12). Namely, a 7-methoxytetradec-4-enoic acid chain
(Figure IV.12.A), a nitrogen containing vinyl chloride moiety (Figure IV.12.B), anda
cyclohexenone ring system (Figure IV.12.C) were observed. Analysis of the 1D 13C
and 1H NMR spectra also revealed N-methyl [1H 6 2.97 (3H), 13C 6 33.48] and% I'VI1I,I2::a3 4C1 9.W 4-% 17:46
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Figure IV.7. LREIMS of malyngamide L.
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Figure IV.12. Partial structures of malyngamide L.Table IV.1. NMR Data for Malyngamide L (80).
Malvnaamide L (80
C-atom 'H nrm (mult. J in Hz)'3C ppm
la 4.0 (d, 14.3) 52.49
b 4.1 (d, 14.3)
2 136.45
3 6.2(bs) 118.72
4 135.71
5 197.30
6 2.65 (m) 48.20
7a 4.13(m) 71.66
b
8a 2.60 (m) 34.68
b 2.78 (m)
9 6.57(m) 143.70
10 1.25(m) 11.25
1' 173.76
2' 2.26 (m) 34.94
3' 2.28 (m) 27.82
4' 5.45(m) 131.05
5' 5.45 (m) 127.21
6' 2.15(dd, 5.8,5.5) 36.42
7' 3.15(m) 80.80
8' 1.41 (m) 33.37
9' 1.27(m) 25.29
10' 1.27(m) 29.76
11' 1.27(m) 29.31
12' 1.27(m) 31.85
13' 1.27 (m) 22.66
14' 0.88 (t, 6.8) 14.11
15' 3.26 (s) 56.40
NCH3 2.97 (bs) 33.48
OH 3.26 (d, 9.6)
7'OCH3 3.29 (bs) 56.54
'H chemical shifts referenced to residualCHC13(6 7.24)
'3C chemical shifts referenced toCDC13center peak (6 77.00)
L
120121
secondary methyl functionalities {1H S 1.25 (3H), 13C S 11.25. Logically, the N-methyl
component was attached to the nitrogen containing portion of Figure IV.12.B).
HMBC connectivites allowed assignment of the secondary methylgroup as a
substituent of the cyclohexenone ring system, as the methylprotons (H-b) clearly
correlated to its carbonyl carbon (C.-5, 13C 5 197.3) anda heteroatom bearing carbon
(C-7, 13C 8 71.66). Possessing the last available position anda chemical shift indicative
of heteroatom influence, the remaining hydroxyl componentwas attached to C-7. By
acetylating 80 at the proposed secondary hydroxyl, the expected downfield shift of the
proton a to the acetate group, H-7 (1H 54.13 to 1H 8 5.23), confirmed this
assessment.
The methoxy fatty acid tail (Figure IV.12) was found to forman amide bond
with the nitrogen of fragment B through HivfflC connectivities to the amide carbonyl
(C-I' S 173.76) from the N-methyl protons and H-i ('H 8 4.01 and 4.10). Fragment B
was joined with the substituted cyclohexenone by HMBC connectivites from H-3 ('H
8 6.2) to C-4 ('3C 8 135.71) and from the olefinic H-9 (1H 8 6.57)to the quaternary C-
2 ('3C 8 136.45). Thus, the planar structure of malyngamide L was completed.
MALYNGAMIDE Q
MalyngamideQ (70)was isolated as a pale yellow oil from the lipid extract of
L majuscula, collected near San Christi Island, Madagascar. LRFABMS (Figure IV.13)
and HRPABMS showed a pseudomolecular ion (M+H at m/Z 569.3053) consistent
with the molecular formula [C29H4607N2C1], indicating a structure with eight degrees% cfl7 : Ol:e9 4f 23-Seg-97 4:I6
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Figure W 13. LRFABMS of malyngamide Q.123
of unsaturation. The JR spectrum possessed absorptions for NHor OH protons
(3313 cm') and amide carbonyl groups (1713, 1630 crn). A UV maximawas
observed at 264 nm, suggestive of one or more conjugatedenone systems.
The structural theme of the ID NMR spectra (Figure JV.14-15) strongly
suggested a malyngamide nature for 70, with an aliphatic carbon chain,an
exomethylene with a vinyl chloride (1H 6 6.03; 13C 6 118.28), three methoxygroups, a
trans disubstituted olefin (1H 6 5.40 2H; 13C 6 127.33 and 130.58), and five resonances
in the amide/ester region of the carbon spectrum (Table JV.2). A pair of unusual
proton shifts (1H 66.88 and 5.10) were found to correlate to two equally intriguing
carbon resonances ('3C 6 95.10 and 95.38, respectively) by HMQC (Figure IV.16).
The assignment of these shifts as members of a conjugated enone system
corresponded well with chemical shift data reported in the literature for malyngarnide
A,81and began to define 70 as a member of the pyrrolidone-type subclass of the
malyngamides.
Similar to nearly all discovered malyngamides, the 1D NMR data and DQF-
COSY (Figure IV.17) couplings described an aliphatic chain consistent with a 7-
methoxy tetradec-4-enoic acid (Figure IV.19.A). DQF-COSY and HMBC (Figure
JV.18) connectivities allowed the elucidation of the amide portion of the molecule,
functionalized by an exomethylene with a vinyl chloride (Figure JV.19.B). In this
partial structure, 'H-'H coupling could be observed from the exchangeable proton of
the nitrogen to the C-7 methylene protons (1H 6 3.94 and 4.10), which in turn showed
HMBC cross peaks to the quatemary olefinic carbon (C-5, 13C 6 135.20), the vinyl14
O:16"
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Figure IV.14. 'H NMR spectrum of malyngarnideQ.14'
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Figure IV.19. Partial Structures of Malyngainide Q (70).130
chloride functionalized carbon (C-6, 13C 6 118.28), and the methylenecarbon (C-4,
6 36.55). The conjugated enone systems of fragments C and Dwere supported by
chemical shift comparisons with the known natural product inalyngamide A.This was
further delineated, as seen in Figure IV.19.C, by HMBC connectivities fromH-2 to C-
1 (13C 6 165.60) and C-3 (13C 6 171.53), the latter of whichwas also attached to a
methoxy group, H-8 (1H 6 3.67, HMBC from H-8 to C-3). Similarly, thepyrrolidone
fragment D assignments were corroborated by HMBC correlations fromH-2"
(1H 6 5.10) to C-I" (13C 6 170.80), C-3" (13C 6 176.66), and themethine carbon C-4"
(13C 662.35). This methine carbon (C-4")was shown to possess a CH2OH group (13C
6 59.51, 1H 64.35 and 3.79) by DQF-COSY correlationsto H-4" (Figure IV.19D).
Summation of fragments A-B accounted for all components of the molecular
formula.
Proton H-4" of fragment D showed HMBC connectivity to C-I of fragment
C, establishing the C-i amide bond as present in malyngamides A and B. Attachment
of fragment B to C-4 was indicated by the observation of HMBC connectivities from
H-2 to C-4 and H-42,bto C-3. The linking of the aliphatic chain of fragment A to the
rest of the structure was supported by HMBC connectivities between the
exchangeable NH proton and C-i' and long range heteronuclear coupling fromH7a,b
to C-I", thus completing the planar structure of malyngamide Q.131
MALYNGAMIDE R
Modestly brine shrimp toxic(LDSO= 18.0 .tg/m1), malyngamide R (71) was
also isolated as a pale yellow oil from the lipid extract of a Malagasy L majuscula.
LRFABMS (Figure IV.20) of 71 revealed an [M+HIr ion cluster characteristic ofa
single chlorine atom. HRFABMS described a compound with a pseudomolecular
weight (M+H at m/ 583.3150) consistent with a molecular formula of
[C3OH48O7N2C1J, again indicating eight degrees of unsaturation. The JR spectrum
indicated an exchangeable proton (3385 cm') and amide/ester carbonyl groups (1713
and 1630 cm'). A UV maximum was observed at 258 nm.
The 1H and 13C NMR (Figure IV.21-22) spectra of 71 displayed signalsvery
closely related to 70 (see Table JV.3); however complicated by the presence ofa 3:1
pair of conformers owing to anNCH3ainide moiety in 71. As a result, proton signals
were doubled for H-2, H-4, H-6, H-7, H-9 and carbons C-2, C-4, C-5, C-6, C-7, C-9,
and C-i'. Despite this complexity, HMQC (Figure JV.23) and HMBC (Figure IV.24)
allowed facile interpretation of these resonances and, used in conjunction with the
data and structure of 70, allowed complete structural assignment of 71 as shown.
To determine the cis ortransnature of the C-7' disubstituted olefin in the
aliphatic chain a modified Bird Sandwich NMR pulse sequence wasemployed.97By
suppressing signals arising from 'H bound to 12C, a 1D 'H spectrum was created
which clearly allowed observation of only 'H bound to '3C. This greatly deconvoluted
spectrum allowed measurement of the3JHH5to equal 15.0 Hz; and therefore in the
transorientation (Figure IV.25).Table IV.2. NMR Data for Malyn2anlides 0 (7O and R (7fl.
Malyngamide0 (70) Malyngamide R (71)
C-atom'H ppm (mult. J'3C pm C-atom 'H ppm (mult, J13C ppm
in Hz) in Hz)
1 165.61 1 164.52
2 6.88 (s) 95.38 2 6.82 (s) 95.10
3 171.53 3 170.90
4a 3.07 (d,14.5) 36.55 4a 2.90(d, 14.7) 36.71
b 4.16(dt,14.5, b 4.44 (m)
1.4)
5 135.20
6 6.03 (s) 118.28
7a 3.94 (d, 14.2) 37.59
b 4.10(d, 14.2)
8 3.67 (s) 55.99
9 3.86 (s) 58.67
1' 172.73
2' 2.15(m) 36.21
3' 2.24(m) 28.35
4' 5.40(m) 130.58
5' 5.40(m) 127.33
6' 2.13 (m) 36.25
7' 3.10 (ddd, 11.5,80.62
12.0, 6.0)
8' 1.37(m) 33.24
9'a 1.23(m) 25.29
b 1.29(m)
10' 1.22(m) 29.68
11' 1.22(m) 29.25
12' 1.23(m) 22.60
13' 1.25(m) 31.77
14' 0.84 (t, 7.0) 14.06
15' 3.26 (s) 56.40
1" 170.80
2" 5.10(s) 95.11
3" 176.66
4" 4.58 (t, 2.4) 62.35
5"a 3.79(m) 59.51
b 4.35(m)
NH 6.01 (dd, 6.5)
OH 4.64 (dd, 6.5)
'H shifts referenced to residualCHCI3(6 7.27)
'3C chemical referenced toCDCI3(8 77.00)
5
6
7a
b
8
9
10
2' a
b
3' a
b
4,
5,
6' a
b
7'
8'
9' a
b
10' a
b
11'
12'
13'
14'
15'
2"
3,,
4,,
5" a
b
OH
6.16 (s)
3.96 (d, 13.5)
4.53 (m)
3.65 (s)
3.86 (s)
2.82 (s)
2.21 (m)
2.29 (m)
2.16 (m)
2.20 (m)
5.41 (m)
5.41 (m)
2.12 (m)
2.17 (m)
3.10 (m)
1.39 (m)
1.24 (m)
1.32 (m)
1.24 (m)
1.32 (m)
1.24 (m)
1.25 (m)
1.24 (m)
0.85 (s)
3.29 (s)
5.09 (s)
4.56(m)
3.80 (m)
4.46 (m)
4.65 (bs)
133.52
119.97
44.62
55.76
58.65
33.88
173.65
33.37
28.12
130.80
127.37
36.98
80.76
33.39
25.33
29.58
31.86
22.72
31.84
14.18
56.29
171.03
95.09
176.98
62.52
59.16
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Figure LV.20. LRFABMS of malyngamide R.14'
7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppir
Figure IV.21. 'H NMR spectrum of malyngamide R.14'
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Figure IV.22. '3C NMR spectrum of malyngamide R.1-1
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Figure W23. HMQC spectrum of malyngamide R.i4
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Figure W24. HMBC spectrum of malyngamide R.138
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Figure IV.25. Suppression of signals arising from 1H-12C by Bird SandwichNMR
pulse sequence allowing observation of3JH4'H5'1H-13C coupling= 16 Hz, and
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Figure IV.26. Malyngamide R (71) with important NOB correlations
shown.139
Investigation of the geometry of the C5-C6 ole fin in 71,as well as of the
acydic methoxy enone, was accomplished utilizing DPFGSE 1D NOE (Figure
Pi.26)Y8NOE correlations were seen from H-2 to the protons of the adjacent OMe
(H-8), thus defining the C2-C3 olefin to possess an B conformation (Figure P7.26-27).
Through space interactions were also observed between H-6 andH4aand H-6 and
Hç8. Correlations were not perceivedbetweenH7aband H-6, nor between the
NCH3protons (H-b) and H-6. Malyngamide Q (70) shared these correlations with
the exception that it does not contain anNCH3group. From this data we deduced a 5
Z stereochemistry in 70 and 71. This differs from that reported for malyngamide A
(66), which possesses an .E olefin at this position, as revealed by NOE between the
NCH3functionality and the vinylproton.81
Because of the unprecedented Z geometry of C5-C6 in 71, we sought to
confirm this result through the use of 1H-13C long-range heteronuclear coupling
constants. In the past, these coupling constants were difficult to obtain on small
samples for a variety ofreasons.99One approach using a PFG-HMBC experiment
with gradient ratios of 5:3:4 selects only the N-type coherence pathways, thereby
precluding the acquisition of phase sensitive data with pure absorption lineshapes.
Another general difficulty is the mixed phase lineshape resulting from the evolution of
1H-1H couplings during the long delay required for 1H-13C heteronuclear couplingsto
emanate in J-IMBC also demands a magnitude mode presentation of the spectra, which
results in poor resolution. Because of thislackof pure absorption lineshape, the two
most popular ways to obtain long-range coupling constants from HMBC spectra140
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Figure 1V27 HMBC spectrum of malyngamide R.141
require the acquisition of a separate reference spectrum and the utilization of an
elaborate peak fitting routine; or the acquisition of several HMBC experiments with
differing delays for the evolution of long-range coupling and subsequent analysis of
the peak intensities for each individualcorrelation.100'101Tosimplifythe detection and
measurement of these couplings, an extremely useful new pulse sequence based on the
well known HSQC sequence, which provides pure absorption lineshapes and
eliminates the phasing problems associated with the evolution of 1H-1H couplings
during the pulse sequence, was developed by Dr. R. Thomas Williamson and Dr.
Brian L.Marquez.99This method is similar to that presented by Skienar and
coworkers but requires fewer gradient pulses and can be set up with only simple
modifications to existing HSQC pulsesequences.99'102Using the HSQMBC pulse
sequence on malyngamide R, we observed a 7.1 Hz3Jcoupling from H-6 to C-7 and a
4.7 Hz3Jcoupling from H-6 to C-4. These coupling constants, obtained directly from
the HSQMBC (Figure JV.28) spectrum, were identical to those calculated by the
procedure described by Titman and Keeler for the quantitative analysis of coupling
constants (data notshown),101and unambiguously verified our observations
concerning the geometry of C-6, thus indicating that the inherently narrow lineshape
of our experiment makes it possible to record accurate heteronuclear coupling
constants taken directly from slices along the F2 dimension, logically excepting the
case of exceedingly small couplings.
With the availability of this new methodology for the determination of the 1H-
13C heteronuclear coupling constants, we verified the geometry of comparable olefins
in two additional malyngamides available from our repository of pure compounds.ppm -______
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Figure IV.28. HSQMBC spectra highlighting the longrange heteronuclear
coupling between H-6 and C-4 & 7 of malyngamide R.143
When the new pulse sequence was applied to malyngamides F (76) and I (78), the
reported B geometry was supported (Figure W.29). That is, the configuration about
thissp2center is opposite that of the geometry determined for malynganiides Q and R.
The methods which we used to define the above stereochemical questions in 70 and
71 exemplify the power of NMR to elucidate molecular subtleties in a non-degradative
fashion. This alternate geometrical stereochemistry has subsequently been observed in
iso-malyngamides A (68) and B (69) and malyngamides 0 (88) and P (89).83
To elucidate the chirality at the stereogenic C-4" carbon, we utilized GCMS
analysis, employing a chiral column, the two enantiomers of serine methyl ester, and
methods commonly used for stereochemical investigations of peptides.103 By
sequentially subjecting malynganiide R to ozonolysis, hydrolysis, and derivatization, we
were able to create the pentafluoropropyl serine methyl ester (PFPSME) from C3'-05'.
This PFPSME derivative obtained from malynganiide R coeluted with the similarly
derivatized L-serine methyl ester standard (16.32 mm), displaying a difference in
retention time of 0.49 mm as compared to the elution of deriviiized D-serine methyl
ester (16.81 mm). Thus, the stereochemistry of C-4" in malyngamide R is defined as
S.
Definition of the stereochemistry of C-7' of the fatty acid chain was implied by
the isolation and investigation of the co-occurring methoxylated free fatty acid.
Malyngamides Q and R shared proton resonances with the co-occurring methoxy fatty
acid. Also, the methoxy fatty acid displayed an optical rotation([a]250 =-8.3,CH2Cl2,
= 0.8) similar to that reported for malyngamide A([a]25=-6.5,CH2C12,c =0.8).81
Precedence for S configuration of this stereocenter in all reportedo
0d145
malyngamides, corroborating 1H NMR spectra of both 70 and 71 and the co-occurring
methoxylated free fatty acid, and the comparable optical rotation of the free fatty acid
and malyngamide A suggest that C-7" also exists in the S configuration for
malyngamides Q and R.146
EXPERIMENTAL
GENERAL EXPERIMENTAL PROCEDURES
NMR spectra were recorded on a Bruker DRX 600, AM 400, and ACP 300
NMR spectrometers. Mass spectra were recorded on a Kratos MS5OTCmass
spectrometer. UV spectra were recorded on a Hewlett Packard 8452A UV/vis
spectrophotometer while FT-JR spectra were recorded on a Nicolet 510
spectrophotometer. Cbiral GCMS analysis was accomplishedon a Hewlett Packard
Gas Chromatograph 5890 Series II with a Hewlett Packard 5971 Mass Selective
Detector, using an Ailtech Capillary Column (CHIRASIL-VAL Phase 25m x 0.25
mm). HPLC separation was accomplished with a Waters M-6000A pump,a Rheodyne
7010 injector, and a Waters Lambda-Max 480 spectrophotometer. Optical rotation
measurements were recorded on a Perkin-Elmer Model 141 po1rimeter.
COLLECTION
Malyngamide L was extracted from a Curaçao collection of L majuscula
collected by hand (0.5 m) on Aug 9, 1994 from Santa Barbara Beach, Curaçao, and
stored in IPA at 20°C until workup. A voucher sample is available from WHGas
collection number NSB-4 AUG 94-3.
Yielding malyngamides Q and R, the marine cyanobacterium,L,ngl?ya majuscula,
was collected by hand from shallow water (2 m) on Apr 8, 1997 at San Christi Island,
Madagascar (48°9'E 13°18'S), and stored at 20°C in IPA until workup. A voucher
sample is available from WHG as collection number MNS-8 APR 97-2.147
EXTRACTION AND ISOLATION OF MALYNGAMIDE L, Q,D R
The defrosted alga was homogenized in CH2Cl2/MeOH (2:1 v/v) and
extracted two times to give a crude extract of 1.08g. This was sequentially
fractionated using VLC (1% to 100% EtOAc in hexanes (v/v), Sephadex LH-20
column chromatography (50% MeOH/MeOH, v/v), and Si gel column
chromatography (80% EtOAc/hexanes, v/v). Final purificationwas obtained using
HPLC (256 x 4.6 mm Ailtech Lichrosorb Diol column, 10 ji; 0.5 MeOH/1.5
EtOAc/8.0 hexanes) to yield pure malyngamide L (0.0039g; 0.36% of total extract).
The IPA preserved alga (16.1 g dry wt) was extracted with CH2Cl2/MeOH
(2:1) two times to give a crude extract of 0.75g. A portion of this (0.70 g) was
fractionated using vacuum liquid chromatography (VLC) on Si gel witha stepwise
gradient of hexanes/EtOAc and EtOAc/MeOH to give nine fractions. Because
fractions seven and eight (eluted 70%-100% hexanes/EtOAc) both contained 70 and
71, they were recombined and subjected to reversed phase chromatography usingan
RP-18 Waters Sep-Pak (85% MeOH/H20) and then RP-HPLC (ODS) in 80%
MeOH/H20 to yield pure 70 (0.032 g, 4.6% of total extract) and 71 (0.0091g, 1.3% of
total extract).
MALYNGAMIDE L (80)
Pure malyngamide L showed[a]25D+17 (EtOH, c 0.1); UV Xmax (MeOH)
206 nm (log c4.49); JR zmax (film) 3416, 2921, 2854, 1680, 1619, 1457, 1090cm1;
FABMS [0.1 N oxalic acid in thioglycerol:glycerol (2:1)] obs. m/[M+I-1](rel int) 468148
(100), 452 (10), 418 (7), 236 (20), 230 (75),199 (40), 145 (28); HREIMS obs.{M-Cl} at
/432.3096 for C26H4204N (L1.7 mmu); 1H and 13C datasee Table JIV.1.
MALYNGAMTDE Q (70)
Pure malyngatnide Q showed[a]25D+2 (MeOH, c 0.8); UV Amax (MeOH)264
urn (log c4.18); JR umax (film) 3313, 2925, 2848, 1713,1630, 1451, 1397, 1319,
1248, 1206, 1164, 1069, 961, 854, 776 cm1; FABMS(3-NBA) obs. m/ (rel int) 569
(60), 537 (80), 507 (25), 426 (55), 395 (70);HRFABMS (3-NBA) obs. {M+J-1]m/Z
569.3053 for C29H4507N2C1 (L -5.9 mmu); obs.[M-CH4O] at m/ 537.2731 for
C28H4106N2C1 (z0.0 mmu); 1H and '3C NMR datasee Table JV.2.
MALYNGAMIDE R (71)
Pure malyngamide R showed[a}25D+2 (MeOH, cO.9); UV Xmax (MeOH) 258
nm (log=4.18); JR umax (film) 3385, 2913, 2854, 1713,1630, 1451, 1385, 1319,
1242, 1200, 1158, 1069, 997, 848, 770 cm1; FABMS(3-NBA) m/Z (rel int) 583 (70),
440 (100), 202 (90), 171 (35); HRFABMS (3-NBA)obs. [M+HT at m/583.3l50 for
Cj-I47O7N2Cl (0.0 mmu); 1H and 13C datasee Table IV.2.
CHJRAL ANALYSIS OF MALYNGAMIDE R (71)
Malyngarnide R was ozonized (1.0mg 71 in 1.0 ml CH2C12, 3mm).The
ozonate was immediately dried in vacuo, and to this vial I ml of 6N HCI was added
and heated in an oven at 110°C for 18 his. The hydrolysatewas dried under a149
constant stream of nitrogen and derivatizated using an Ailtech PFA-IPA Amino Acid
Kit (#18093). The dried hydrolysate was treated with 0.2 N HC1 for five minutes at
110°C, then dried under a constant stream of nitrogen. To this vial, 150.tlof acetyl
chloride and 500 p1 of IPA were added, then the vial was heated for 45 mm at 110°C.
After drying with a constant stream of nitrogen, the derivatizing agent,
pentafluoropropyl isopropionic acid (1 ml in 2 ml CH2C12) was added. The vial was
heated to 115°C for 15 mm then blown dry with nitrogen. The derivitized product was
then solubilized in hexanes. To be used as standards, 1 mg of each of the serine
methyl ester enantiomers (L and D) was weighed into a tared vial and subjected to the
identical derivatization sequence as the ozonyzed hydrolysate of 71, as detailed above.
All samples were gas chromatographed under identical conditions, beginning with a
sustained initial oven temperature of 50°C (4 mm), a 3°C/mm ramp from 50°C to
150°C was followed by a 20°C/mm ramp from 150°C to 180°C. The derivatized
malyngamide R eluted at 16.32 mm, as did the derivatized standard L-serine methyl
ester. The derivatized D-serine methyl ester was detected at 16.81 mm.
BRINE SHRIMP ToxIcITY BIOASSAY
Evaluation for brine shrimp toxicity was performed as previouslydescribed.104
using Artemia sauna as the test organism. After a 24 hr hatching period, aliquots of a
10 mg/mI stock solution of 71 were added to test wells containing 5 ml of artificial
seawater and brine shrimp to achieve a range of final concentrations from 0.05-100
ppm. After 24 h the live and dead shrimp were tallied.150
ICTHYOTOXICITY BIOASSAY
Using Carassius auratus (goldfish) as the test organism, the icthyotoxic potential of
our samples were assessed as previouslydescribed.105Aliquots of a 10 mg/mi stock
solution of our samples (in EtOH) were added to 50 ml beakers containing 40 ml of
distilled H20 to achieve a range of final concentrations from 1-100ppm. A single test
organism was added to each beaker. The experiments were concludedupon death of
test organism (floating on surface and lack of respiratory function) or at I hr, with 15
mmobservation intervals.151
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CHAPTER V.
THE ISOLATION ANDSmucTu1uELUCIDATION OF LYNGBYABELLIN B
AND TORTUGIN: SUPPORT FOR THE CYANOBACTEmAL OMGIN OF
SEVERAL MOLLuscAN CYCLIC DEPSIPEPTIDES
ABSTRACT
The lipid extract of a Lysgbj'a majuscula collected from the Dry
Tortugas, Florida has yielded lyngbyabellin B and tortugin, new biologically
active cyclic depsipeptides. Lyngbyabellin B resembles dolabellin, originally
derived from the sea hare Do/abel/a auricu/aria, and lyngbyabellin A, recently
isolated from L majuscula. Tortugin is most closely related to the molluscan
derived onchidins A and B, kulolide, and kulokainalide-1 and also to the L
majuscda derived yanucamides A and B. The discovery of these compounds
from a cyanobacterial source further supports cyanobacteria as the primary
producers of many secondary metabolites previously attributed to invertebrate
de novo biosynthesis. Isolation of these metabolites was carried out through
preparative liquid chromatography with final purification by repetitive reversed
phase HPLC. Structure elucidation was accomplished utilizing 1D and 2D
NMR spectroscopic characterization. Chiral analysis of both compounds was
accomplished through chiral GC/MS derivatization techniques, Marfey's
analysis, and semi-synthesis/menthyl carbonyl chloride (MCC) derivatization.154
INTRODUCTION
Cyanobacteria are phenomonal producers of structurally-intriguing and
biologically-active secondary metabolites. Recently, cyclic depsipeptides, many
incorporating unusual appendages and presumably arising from the NRPS
biosynthetic pathway, have become a dominant theme in cyanobacterial natural
products literature. Notable biological activities have been observed for many of
these, including antifungal (hormothamnin A,
93),b06neurotoxic (antillatoxin,94),107
and antiproliferative [cryptophycin-1 (23) and 52(24),29 lyngbyabellins (95 & 96),b0hb0
hectochlorin(97)111] activities (Figure V.1).
Products of the NRPS pathway, common in bacteria and fungi, have been
discovered in the marine environment from organisms such as tunicates,2 sponges,3
andmolluscs.114The isolation of yanucantide A (98) and B(99),h15lyngybabellin A
(95)108and B (96),1®hb0 georgamide (100),h16 23 and 24, 97, tortugin(101),h17 and
carliamide (102)123 from cyanobacterial sources has displayed their ability to utili2e this
pathway as well (Figure V.1). Such fmdings have contributed to the debate over the
organism responsible forde novosynthesis of many marine natural products.
Certain structural motifs, previously derived solely from molluscan secondary
metabolite studies, have begun to appear as hallmarks of cyanobacterial biosynthesis,
such as the incorporation of (3-amino acids, (3-hydroxy acids, and unusual amino acid-
like residues.33 As many gastropods (molluscs) are herbivorous grazers, it is
conceivable that cyanobacteria would be ingested by the mollusc and the secondary
metabolites sequestered (and potentially subjected to biotransformation) by the
predator. Cyanobacterial compounds could then proceed further up the food chainHQ
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with sequential predation events. Thus, when an herbivore (or predator of that
herbivore) is investigated, the secondary metabolites which derived from the
cyanobacteria would appear to have been created by the sample organism. A potential
example is the sea hareDolabellaauricularitr, credited in the literature as the producer of
some of the fields most recognized and storied natural products, including the
dolastatins (13 and 103-107) and dolabellin (108)23The cyclic depsipeptide
dolastatins (some examples in Figure V.2) possess structural motifs that have become
recognized as characteristic of cyanobacterial secondary metabolites such as the
incorporation of distinctive constellations of atoms (e.g. dolaphine and pyrrolidone
units, Figure V.3.A), alternating heterocydic ring/aliphatic residues (FigureV.3.B),33
the presence of a f3-hydroxy acid containing an acetylenic terminus (Figure V.3.C), the
rarely encountered Ahp moiety (3-amino-6-hydroxy-2-piperidone; FigureV.3.D),33a
lactonized L-Thr (FigureV.3.E),33and a high degree of N-methylation (Figure V.3F).
Interestingly, the alternation of heterocycic rings and aliphatic residues has also been
observed in compounds isolated from tunicates (such as the patellamides), which are
known to live symbiotically with the prokaryoticProchioron sp.8While dolabellin (108)
is not a cyclic depsipeptide, it bears strong structural semblance to the lyngbyabel]ins
(Figure V.4); maybe most strikingly, sharing the same eight carbon dichlorinated-
hydroxy acidresidue.11'
An unusual terminally acetylated residue incorporated into a growing number
of cyanobacterial natural products can be found in a variety of forms, including both
f3-amino and f3-hydroxy acid in a-methyl/gem-dimethylated versions (Figure V.5). The
Dhoa (dihydroxy octynoic acid) residue of 98 and 99, rarely seen in nature, had onlyIf','
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Figure V.5.-hydroxy and amino octynoic acids found in some
cyanobacterial cyclic peptides.161
been discovered in kulolide (113) from the mollusc Phihinopsis speciosa, before the
isolation of the yanucamides from a mixed collection of Lmajusciila/Scbiotbnxsp.h15'12°
This residue is also present in the L majuscula derived, georgarnide(100).h16The
obvious structural similarities between the yanucarnides, kulolide, and georgeamide
suggest the potential of a cyanobacterial origin for these metabolites. A modified
version of Dhoa can be seen in the lyngbyabellins and hectochiorin, wherein the
terminal acetylene is replaced a dichioromethyl moiety.
Onchidium sp., a pulmonate mollusc, is one of the few organisms which has
provided secondary metabolites using the Amo moiety (amino methyl octynoic acid);
incorporating it into onchidins A (109) and B(110).1211To date, cyanobacteria have
supplied the only other reports of this unusual residue with the discovery of
malevamide C from SyixplocaIaete-vi,idis.128As in the previous example, cyanobacteria
appear responsible for the elaboration of secondary metabolites utilizing the Amo
moiety. This line of thought is further strengthened by the discoveries of tortugin
(101) and carliamide (102) which both display the Amo residue observed in onchidin A
and B (FigureV.6).117'121'1
Additional support for this hypothesis can be gleaned from further
investigation of P. speciosa. From this organism, tolytoxin 23-acetate (111),
pupukeamide (112), and 113 wereisolated.120'124'1As in previously discussed examples,
112 contains the 'cyanobacterial' N,O-diinethyltyrosine unit, while 111 has been
previously reported as a cyanobacterial secondarymetabolite.124Also, supporting the
reports of secondary metabolite flow through the food chain,Onchidin A (109)
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Figure V.6. Secondary metabolites isolated from marine invertebrates which either
bear strong resemblence to cyanobacterial compounds or have also been isolated
from a cyanobacterial source.163
laboratory experimentation has revealed that P. .rpeciosa is able to feedupon Sy1ocheilus
longicauda(a well known grazer of cyanobacteria).12°164
RESULTS AND DISCUSSION
LYNGBYABEWN B
Lyngbyabellin B (96) was isolated as a pale yellow oil (0.28% of the organic
extract, 7.1 mg) and displayed a UV maximum at 246 nm (log i 4.20) and an optical
rotation of[cr]D25+ 158° (CHCL3, c 0.1). LRFABMS (Figure V.7) described a
compound with a molecular ion at [(M+H) at m/ 679] and an isotope pattern
indicative of the presence of two chlorine atoms. HRFABMS showed a
pseudomolecular ion [(M + H) at m/ 679.1794] consistent with the molecular
formulaC28H4107N4C12S2(A 2.3 mmu), indicating a structure with ten degrees of
unsaturation. The JR spectrum revealed absorptions indicative of NH/OH protons
(3323 cm1), amide/ester carbonyls (1718, 1674 cm1), andgem-dimethyl moieties (1234
cmt). Analysis of the 1D 1H and 13C NMR data indicated a short aliphatic chain, two
NH protons, three gem-dimethyl groups, agem-dichloromethyl functionality, four
methines bound to heteroatoms, and six downfield resonances in the amide/ester
carbonyl chemical shift range (Table V.1). Interpretation of 1D NMR (Figure V.8-9)
data in concert with 2D NMR experiments, including 1H-13C HSQC (Figure V.10), 1H-
l3HSQC-TOCSY (Figure V.11), 1H-13C HMBC (Figure V.12), and 1H-15N PEP-
HSQC-TOCSY (Figure V.13), defined partial structures A-G (Figure V.14).
Diagnostic chemical shifts and HMBC correlations from the methine proton
(H-3) to three quaternary carbons (C-i, 2, and 5) allowed assembly of the thiazole
partial structure fragment A. Similarly, in fragment D, connectivity could be observed
from the methylene protons (H-17) to a pseudo-a carbon (C-i6) and a desbieldedDS% I@t1005.2: Q0:18 +f8 15-Dec-97 16:27
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Table V.1. NMR Data for Lyngbyabellin B (96).°
Residues' Atom#'H ppm (mult, J in'3C (ppm) HMBCC 'H-'5N PEP-
Hz) HSQC-TOCSY"
Thiazole(A) I - 161.10 - -
2 - 146.82 - -
3 8.27 (s) 129.45 1,2, 5 -
4 - -
5 - 171.13 - -
6 - - - -
Valine (B) 7 5.10 (t, 9.6) 55.58 5, 8, 9, 10, 12 11
8 2.36 (dq, 9.7, 6.7) 33.89 7, 10 11
9 0.74 (d, 6.8) 19.73 7, 8, 10 11
10 0.99 (d, 6.8) 19.30 7, 8, 9 11
11 8.07(bs) - 12 11
Glycine(C) 12 - 167.69 - -
13a 3.61 (dd, 10.0, 2.3) 43.15 12, 15 14
13b 4.64 (dd, 10.2, 10.0)43.15 12, 15 14
14 6.68(dd,9.8,1.6) - 14
Thiazoline (D) 15 - 170.89 - -
16 5.27 (d, 9.6) 78.67 15, 19 -
17a 3.27 (dd, 9.8, 1.8) 34.44 15, 16 -
17b 3.75 (dd, 10.6, 1.5) 34.44 15, 16, 19 -
18 -
19 - 177.63 -
20 - -
t-Hydroxy valic21 5.72 (d, 1.6) 78.58 19, 26 -
Acid (E)
22 - 74.13 - -
23 1.81(s) 26.19 21,22,24 -173
Table V.1. (Continued) NMR Data for Lyngbyabellin B (96).a
24 1.44 (s) 29.29 21, 22, 23 -
OH 5.55 (bs) - 22, 23 -
25 - - - -
DDHOe (F&G) 26 - 172.62 - -
27 - 47.24 - -
28 1.33 (s) 22.81 26, 27, 29, 30 -
29 1.41 (s) 24.45 26, 27, 28, 30, 31-
30 5.32 (dd, 11.0, 3.3)78.45 1, 26, 27', 33 -
31a 1.68(m) 21.91 30,32 -
31b 1.76(m) 21.91 30,32 -
32a 1.93(m) 29.23 31 -
321, 1.70(m) 29.23 31 -
33a 2.05 (m, obs) 48.80 31, 32, 34 -
33b 2.25 (ddd, 14.6, 48.80 31,32,34 -
11.3,4.4)
34 - 90.01 - -
35 2.05 (s) 37.43 33, 34 -
a1H chemical shifts referenced to residual CHC1, (8 7.27; 13C chemical shifts referenced to center peak
of CDC1, (6 77.00).Residue names given by dominant moiety type. For partial structures see Figure 1.
PIMBC data are reported as proton (atom #) displaying connectivity to indicated carbon. dIHISN
PEP-HSQC-TOCSY data are reported as proton (atom #) displaying connectivity to indicated nitrogen.
7,7-dichloro-2,2-dixnethyl-3-hydroxy octanoic acid. TWeak correlation.174
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Figure V.14. Partial structures of lyngbyabellin B.
Figure V.15. Key HMBC correlations used in the
sequencing of partial structures A-G of lyngbyabeliin B.175
quaternary carbon (C-19), suggesting a thiazoline partial structure. The 1H-15N PEP-
HSQC-TOCSY NMR experiment clearly demonstrated connectivity between N-li
and the corresponding a, 13, and y protons of fragment B. Likewise, both methylene
protons of the glycinyl residue correlated to the nitrogen in fragment C (Figure V.13-
14). Partial structures E and F were assembled based on their chemical shifts and
HMBC data. Particularly revealing for fragment E were HMBC correlations to the
pseudo-a carbon (C-21) from both methyl groups of the <gem-dimethyl pair,as well as
connectivity observed from the proton of the tertiary alcohol to the midfield
quaternary carbon (C-22) and one of the gem-dimethyl pair (C-23). Similarly, fragment
F was defined by HMBC cross peaks descriptive of a gem-dimethyl functionality
adjacent to an amide/ester carbonyl. The aliphatic chain of partial structure G was
primarily elucidated by following the 1H-'H spin system using 1H-13C HSQC-TOCSY.
Definition of the gem-dichloro arrangement was accomplished by consideration of its
13C NMR chemical shift (C-34, 690.01), which is comparable to the gem-dichloro
functionality in dolabellin (108,C-7),119and HMBC correlations from the adjacent
methyl (C-35) and methylene groups (C-33). These partial structures account for all
atoms in the molecular formula of 96.
Assembly of the planar structure of 96 was accomplished primarily through
HMBC correlations (Figure V.15). The thiazole containing partial structure A was
placed adjacent to B by HMBC correlations observed between the pseudo-a hydrogen
(H-7, 65.10) of the valine-like residue B to thesp2hybridi2ed carbon of residue A (C-5,
6171.13). H-7 also displayed heteronuclear connectivity to the carbonyl terminus, C-176
12 (6 167.69), of the glycinyl residue (Figure V.15.C). The methylene protons of this
latter residue (H2-13, 63.61 and 4.64) showed HMBC crosspeaks to C-15 (6170.89) of
partial structure D. Correlations were also observed between C-19 (6177.63) of partial
structure D and the pseudo-a hydrogen of E (H-21, 65.72). Substructures E and F
were connected through an ester bond by observing long-range heteronuclear
coupling between H-21 and the C-26 carbonyl of F (6172.62), and consideration of
the 13C NMR chemical shift of C-21 (678.58). Correlations between H-30 (65.32) and
the quaternary carbon containing agem-dimethyl group (C-27, 647.24) allowed
connection of G and F. The planar structure of 96 was completed by linkage of
partial structures G and A by observation of an HMBC correlation between H-30 and
the C-i carbonyl (6161.10). The ester nature of this linkage was established by
consideration of the chemical shift of C-30 (678.45).
The absolute stereochemistry at C-7 was defined using chiral GC/MS analysis
(Ailtech capillary column, CHIRASIL-VAL Phase 25 m x 0.25 mm). Lyngbyabellin B
was ozonized (0.2 mg, CH2C12, I mm, ambient temperature), hydrolyzed (6N HC1, 18
hr, 118°C), and derivatized to yield N-pentafluoropropionyl isopropyl ester derivatives
(Ailtech PFP-IPA Amino Acid Kit). The resulting derivati2ed valine residue of 96,
and identically derivatized valine standards (1 mg each of L- and D,L-valine) were
subjected to chiral GC/MS analysis (see experimental). The valine derivative obtained
from 96 eluted at t14.34 mm, as did the standard L-valine derivative, thus defining
C-7 as having S stereochemistry (the D-valine derivative eluted withtR13.59 mm).177
Interestingly, of the 7 partial structures of lyngbyabe]lin B (Figure V.14.A-G),
only one is an underivati2ed amino acid residue (glycinyl partial structure C). Partial
structures A and D may be formed by condensation of cysteine residues to produce
thiazole and thiazoline rings,respectively.126Partial structures B and E are modified
valine residues. Partial structures F and G are similar to the gem-dichloro aliphatic
chain of dolabellin (108), isolated from the sea hare Do/abe/laauricularia.1'6
Lyngbyabellin B (96) was toxic to brine shrimp (Artemiasauna)104with anLD50
of 3.0 ppm and active against Candida albicans (ATCC 14053) in a disc diffusion
assay,127 giving a 10.5 mm zone of inhibition at 100 pg/disc anda slight halo at 10
ig/disc. The striking structural parallel between lyngbyabellin B (96) and dolabellin
(108) strongly supports a cyanobacterial origin for the latter metabolite.
In our laboratory, compound 96 was originally named "tortugamide" to reflect
its origin from L majuscula collected in the Dry Tortugas, Florida. However, upon
recognition that 96 was discovered simultaneously by both our group and that of
Professor RE. Moore (Univ. of Hawai'i), and in light of the earlier publication of
lyngbyabellin A(95),12we have adopted the name "lyngyabellin B" for compound
96.b0hb0
TORTUGIN
Tortugin (101) was isolated as a biologically active (brine shrimp LD50= 4.0
ppm) pale yellow oil from the lipid extract of L majuscula. LRFABMS (Figure V.16)
described a compound with a molecular ion of [(M+H) at m/Z 625]. HRFABMS
showed a pseudomolecular ion (M+H; 625.3965) consistent with a molecular formulaFigure V.16. +FABMS of tortugin.
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[C35H5206N4+ J-I], indicating 12 degrees of unsaturation. The JR spectrum indicated
absorptions for NH protons (3299 cm1), a carbon-carbon triple bond (2214 cm1), and
amide carbonyl groups (1735, 1652 cm1). A UV maxima was observed at 210 nm,
suggestive of amide bonding.
The ID 1H (Figure V.17) and 13C NMR (Figure V.18) of 101 is complicated by
a near doubling of resonances, as compared to what our molecular weight would
suggest, due to the presence of a pair of 3:2 conformers caused by rotation about two
NMe amide bonds. InC6D6and CD3OD partial reduction of the conformers was
observed. Careful interpretation of 1D and 2D NMR data allows the separation of
resonances into conformer sets each forming the complete natural product. Structural
analyses were accomplished using the major component.
Interpretation of 1D NMR data and 2D NMR experiments, including 1H-1H
HSQC-TOCSY (Figure V.19), 1H-13C HSQC (Figure V.20), 1H-13C HMBC (Figure
V.21), and 1H-15N PEP-HSQC-TOCSY (Figure V.22) defined partial structures A-E
(Figure V.23). Partial structure E was confirmed through JR (carbon-carbon triple
bond at 2214 cm1) and the HMBC measurement of a 1H-13C
1Jcoupling constant of
250 Hz, indicative of a terminal acetylene. Particularly insightful in deciphering the
non-NMe amino acids (A and E) was the 1H-'5N PEP-HSQC-TOCSY experiment
pioneered in our laboratory by Dr. R. Thomas Williamson and Dr. Brian L. Marquez,
which allowed visualization of the 1H-1H spin system "sorted" by their respective
nitrogens. Similarly, HSQC-TOCSY was primarily responsible for the development of
the remaining partial structures (B,C,D) through the examination of the 1H-1H
coupling of their 'R' side chains. The combination of the nitrogen edited and standard?HiO. N----- "S
8.58.07.57.06.56.05.55.04.54.03.53.02.52.01.51.0 0.5 pprr
Figure V.17. 1H NMR spectrum of tortugin.
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Figure V.18. "C NMR spectrum of tortugin.
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Figure V.19. HSQC-TOCSY of tortugin.
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Figure V.20. HSQC of tortugin.
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Figure V.21. HMBC of tortugin.
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Figure V.22. IH-15N PEP-HSQC-TOCSY of tortugin. The correlationsrepresenting
the non-NMe amino acid residues of the two conformersare contained within the boxes.
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Table V.2. NMR Data for Tortugin (1O1y.
Residue" Atom#'H ppm (mult, J in Hz) '3C(ppm)
L-Phe 1 171.11
2 5.10(m) 55.27
3 7.78
4a 2.97 (m)- 40.22
4b 3.27 (dd, 4.7, 14.6)
5 137.0
6 7.18(m) 129.3
7 7.15(m) 126.6
8 7.35 (m) 128.4
9 7.25(m) 126.4
10 7.26(m) 128.3
L-NMe-Leu 11 169.3
12 4.42(m) 59.29
13
14 1.5(m)
15 1.98(m) 34.65
16 1.0(s) 22.4
17 1.01 (s) 23.0
18 2.32 (s) 29.04
L-NMe-AIa 19 172.93
20 4.65(m) 51.72
21
22 1.38(s) 15.19
23 3.15(s) 31.30
L-}HvIPK 24 - 171.32
25 5.05 (d, 5.8) 76.49187
Table V.2. (Continued) NMR Data for Tortugin (1O1)a.
26
27 1.99(m) 35.76
28 1.52(m) 24.35
29 0.96 11.45
30 1.08 15.00
31 174.50
32 2.75 (m) 40.97
33 4.05 (m) 53.23
34 7.84 (bs)
35 1.86(m) 34.51
36 1.49 (m) 24.65
37 2.20(m) 18.32
38 84.01
39 1.95 (m) 68.64
40 1.16(s) 15.60
1H chemical shifts referenced to residual CHC13 (7.27); '3C chemical shifts
referenced to center peak of CDCI3 (ö 77.00). bResidue names given by dominant
moiety type. 'FIMPA is hydroxy methyl pentanoic acid. dMno is amino methyl
octynoic acid.188
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Figure V.23. Partial structures of tortugin.
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Figure V.24. Assembling the partial structures of tortugin.189
HSQC-TOCSY experiments allowed relatively facile building of the five partial
structures of tortugin. This is due to the structure of 101 (and the predominance of
other cyclic peptides and depsipeptides) allowing clear visualization of the 1H-1H spin
system of the amino or hydroxy acid's side chains. Correlations from the a-proton to
protons within other subunits will not typically occur, as the coupling relay must
proceed through a protonated carbon (for HSQC-TOCS'Y) or nitrogen (for 1H-'5N
PEP-HSQC-TOCSY).
The assembly of the partial structures into the planar structure of tortuginwas
accomplished primarily through the interpretation of HMBC correlations from thea
or pseudo-a proton to the carboxyl carbon of adjascent subunits (Figure V.24). The
Phe a-H (H-2) displayed HMBC connectivity to the NMe-Leu carbonyl (C-Il). From
the NMe-Leu a-H (H-12), a correlation into the NMe Ala residue could beseen
through its carbonyl carbon(C-19). HMBCcross-peaks from the NMe-Alaa-H(H-
20) to the HMPA (hydroxy methyl pentanoic acid) carbonyl (C-24) allowed linking of
these two residues. The remaining residue was attached to the HMPA, formingan
ester bond, owing to heteronuclear connectivity between the HMPA a-H (H-25) and
the Amo carbonyl (C-31). The resulting straight chain depsipeptide partial structure
accounted for all of the atoms of the molecular formula for 101. Cydlization by
forming an amide bond between the Amo and Phe residues was accomplished
through the observed correlations between the Amo a-H (H-33) and the Phe carbonyl
(C-i), thus completing the planar structure of tortugin.190
In order to elucidate the chirality of the Phe ct-carbon, chiral GC/MS analysis
was utilitzed. By subjecting tortugin to acid hydrolysis followed by the appropriate
derivatization, the N-pentafluoropropyl isopropionyl ester of the phenylalanine
derivative (PFPIP-Phe) was created. This PFPIP-Phe derivative of tortugin co-eluted
with the similarly derivitized L-phenylalanine standard (tR 16.32 mm), and displayed a
difference in retention time of 0.49 mm as compared to the elution of the derivatized
D-Phe standard (tR 16.81 mm). The stereochemistry of the NMe-Ala and NMe-Leu
residues was deduced using HPLC and Marfey's analysis. HPLC analysis followed
acid hydrolysis and Marfey's reagent derivatization, and resulted in the coelution of
NMe-Ala with the derivatized standard L-NMe-Ala (tR 26.51 mm; D-NMe-Ala tR 27.3
mm).111The liberated and derivatized NMe-Leu residue also co-eluted with its NMe-
L-Leu standard (tR 32.63; D-NMe-Leu tR 34.52). For the HMPA residue, acid
hydrolyzed tortugin was reacted with menthoxy carbonyl chloride (MCC) to form the
menthyl carbonate of HMPA.128 Since HMPA has two chiral centers, four standards
were required for proper analysis. The L and D-HMPAs were commercially available
and the L-allo and D-allo-HMPA were synthesized from L-allo and D-allo-isoleucine,
respectively, by a diazotization reaction (Figure V.25 and 26).129130 The chemical
identity of the synthesized products was confirmed by FABMS. The four derivatized
standards were separable from each other by GC/MS. The menthyl carbonate
derivative of HMPA obtained from tortugin co-eluted with the derivatized L-HMPA
standard (tR 20.7 mm; t100° C for 0.5 mm, At = 3°/mmto 240° C; D-HMPA tR
20.95, D-allo-HMPA tR 20.80, L-allo-HMPA tR 20.37). The 1-IMPA unit of tortugin
could thus be defmed as L, or S,S HMPA.0
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Figure V.25. The four stereoisomers of HMPA, the synthesis of L-allo and D-allo-HMPA, and the synthesis of
menthyl carbonates for GC/MS analysis (MCC = Menthoxy carbonyl chloride).
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Figure V.26. GC/MS analysis of MCC derivathed HMPAs and tortugin
(tR = retention time). A. L and D-HMPA-MCC (tR 20.70 and 20.95, respectively).
B. L-HMPA-MCC (tR 20.70). C. L-allo-HMPA-MCC (t2O.37). D. D-allo-HMPA-
MCC (tR 20.80). E. HMPA-MCC (from tortugin, t 20.70). F. Tortugin HMPA-MCC
and L-allo-HMPA-MCC comjection. G. Tortugin HMPA-MCC and D-allo-HMPA-
MCC coinjection. H. Tortugin-HMPA-MCC and L/D-HMPA-MCC coinjection.
Notice the increase in L-HMPA. I. Tortugin-HMPA-MCC and L-HMPA-MCC
coinjection.EXPERIMENTAL
GENERAL
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NMR spectra were recorded on a Bruker DRX 600 MHz spectrometer. Mass
spectra were recorded on a Kratos MS5OTC mass spectrometer. UV spectra were
recorded on a Hewlett Packard 8452A diode array spectrophotometer while FT-JR
spectra were recorded on a Nicolet 510 spectrophotometer. Chiral GC-MS analysis
was accomplished on a Hewlett Packard Gas Chromatograph 5890 Series II Gas
Chromatograph with a Hewlett Packard 5971 Mass Selective Detector using an Ailtech
capillary column (CHIRASIL-VAL Phase 25 m x 0.25 mm). HPLC separation was
accomplished with Waters M-6000A and 515 pumps, a Rheodyne 7010 injector, and
Waters Lambda-Max 480 and PDA 1515 spectrophotometers. Optical rotation
measurements were recorded on Perkin-Elmer Model 141 and 252 polarimeters.
BIoLoGIcAL MATERIAL
The marine cyanobacterium,Ljngbjya majuscula,was collected by hand from
shallow water (2 m) on 15 November, 1995 at Bush Key, Dry Tortugas, Florida, and
stored at 20°C in IPA until workup. A voucher sample is available from WHG as
collection number DBK-15 NOV 95-4. The original collection was made byJ.V.
Rossi.194
EXTRACTION AND ISOLATION OF LYNGBYABELLIN B (96)
The IPA preserved alga (476 g dry wt) was extracted withCH2C12(2:1) two
times to give a crude extract of 2.6 g. A portion of this (2.5 g) was fractionated using
vacuum liquid chromatography (VLC) on Si gel with a stepwise gradient of
hexanes/EtOAc/MeOH to give 8 fractions. Because fractions 6 and 7 (eluted 50-
75% EtOAc/hexanes) contained 96, they were recombined and subjected to VLC
(hexanes/EtOAC/MeOH) and collected as 7 fractions. Fractions 5 and 6 (60-100%
EtOAc/hexanes) both possessed 96 and were recombined. This fraction was further
purified over a Waters Sep-PakC18solid phase extraction cartridge (75%
MeOH/H20). ODS RP-HPLC (Phenomenex ODS, 250 x 10 mm, 5 .x) in 90%
MeOH/H20 afforded a single peak which was further purified using ODS RP-HPLC
(Phenomenex ODS, 250 x 4.60 mm, 5p) in 70% MeOH/H20 to yield 96 (peak
centered at 14 mm, 7.1 mg, O.3% of extract).
ExmAcnON AND ISOLATION OF TORTUGIN (101)
The IPA preserved alga (125.8 grns dry wt) was extracted with
CH2Cl2/MeOH (2:1) two times to give a crude extract of 3.0 g. A portion of this (2.5
g) was fractionated using vacuum liquid chromatography (VLC) on Si gel with a
stepwise gradient of hexanes/EtOAc and EtOAc/MeOH to give eight fractions.
Because fractions six and seven (eluted 60%-100% Hexanes/EtOAc) both contained
101, they were recombined and subjected to RP-HPLC (ODS) in 90% MeOH/H20.
Final purification was accomplished using RP-HPLC (ODS) in 70% MeOH/H20 to
yield pure 101 (51 mg, 0.02% of total extract).195
LYNGBYABELLIN B (96)
Pure lyngbyabellin B showed an[a]025+ 158° (CHCI3, c 0.1); UV ?MeOH)
246 nm (log C 4.20); JR v(film) 3323, 2959, 1718, 1674, 1513, 1234, 1145; FABMS
(3-NBA) obs. m/ (rel int) 679 (100), 665 (15), 201 (30), 166 (70); HR FABMS (3-
NBA) obs. [M + H] m/Z 679.1794 forC28H4107N4C12S2(A 2.3 mmu); 1H and 13C
data see Table V.3
TORTUGIN (101)
Pure tortugin showed[a]038 (MeOH, c 1.0); UV A.me,c (MeOH) 210 nm
(log=15,000); JR vmax (film) 3299, 2948, 2114, 1735, 1652, 1524, 1185, 695cm1;
FABMS (3-NBA) obs. m/ (rel int) 625 (100), 534 (10), 444 (23), 182 (100);
HRFABMS (3-NBA) obs. [M+FI] m/Z 625.3965 forC35H5306N4(A 0.8 mmu); 1H
and 13C data see Table V.4
CHIRAL ANALYSIS OF LYNGBYABELLIN B
Lyngbyabellin B was ozonized (0.2 mg of 96 in I mL CH2C12, 1 mm, ambient
temperature), immediately dried in vacuo, and hydrolyzed (1 ml 6 N HC1,110°C, 18 hr).
The hydrolysate was dried under nitrogen and derivatized using anAiltech PFP-IPA
Amino Acid Kit (#18093). The dried hydrolysate was treated with 0.2 NHC1 (5 mm
at 110°), and then again driedunder nitrogen. To this, 150..tlof acetyl chloride and
500 j.tl of IPA was added and heated at 110° for 45mm.After drying with nitrogen,196
the derivatizing agent, pentafluoropropionic anhydride (1 mL dissolved in 2 mL
CH2C1), was added and the solution heated at 115 °C for 15 mm, blown dry with
nitrogen, and then solubilized in hexanes. For standards, 1 mg each of the L and D/L
valine were subjected to the identical derivatization sequence as the ozonized
hydrolysate of 96. All samples were analyzed by gas chromatography under identical
conditions, beginning with a sustained initial oven temperature of 50°C (4 mm), a 3
°C/min ramp from 50°C to 150 °C and concluding with a 2 0°C mm ramp from 150
°C to 180 °C. The derivaiized lyngbyabellin B fragment as well as the derivatized L-
valine standard coeluted at tRl4.34 mm. The derivatized D-valine eluted at tR=l3.59
CHIRAL ANALYSIS OF TORTUGIN
Tortugin was hydrolyzed (1 ml) by incubating in 6 N HCI in an oven at 110°C
for 18 hrs. The hydrolysate was dried under a constant stream of nitrogen.
Derivatization was accomplished using an Ailtech PFP-IPA Amino Acid Kit
(#18093). The dried hydrolysate was treated with 0.2 N HC1 for five minutes at
110°C, then dried under a constant stream of nitrogen. To this vial, 150 p1 of acetyl
chloride and 500 p1 of IPA were added, then the vial was heated for 45 mm at 110 °C.
After drying with a constant stream of nitrogen, the derivatizing agent,
pentafluoropropionic anhydride (1 ml in 2m1 CH2C1) was added. The vial was heated
to 115°C for 15 mm then blown dry with nitrogen. The derivatized product was then
solubilized in hexanes. To be used as standards, 1 mg of each of the phenylalanine
enantiomers (L and D) was weighed into a tared vial and subjected to the identical197
the identical derivatization sequence as the ozonyzed hydrolysate of 101, as detailed
above. All molecules were gas chromatographed under identical conditions.
Beginning with a sustained initial oven temperature of 50°C (4 mm), a 3 °C/min ramp
from 50 °C to 150 °C was followed by a 20 °C/min ramp from 150 °C to 180 °C. The
derivitized tortugin eluted at 16.32 miii, as did the derivitized standard L-
phenylalanine. The denvatLzed D-phenylalanine was detected at 16.81 mm. A portion
of the hydrolyzed tortugin was also reacted with Marfey's reagent Nct-(2,4-dinitro-5-
fluoro-phenyl)-L-alaninamide (FDAA) in order to examine theNCH3amino acids
present.131HPLC analysis of the derivatized tortugin amino acids and the FDAA-
derivatized amino acid standards was accomplished using an aqueous gradient of
triethylammonium phosphate (50 mlvi, pH 3.0)/MeCN 90:10 to 60:40 (UV detection
at 340 rim). The tortugin amino acids coeluted with the L-Nme Ala (tR 26.51 mm) and
L-Leu standards (t32.63). An additional portion of the hydrolyzed tortugin sample
was methylated with diazomethane then reacted with (1R)-(-)-menthyl carbonyl
chloride to form the (1R)-(-)-menthyl carbonate methyl ester derivatives in preparation
for GC/MS analysis. The analytical standards utilized were the commercially available
L-HMPA and D-HMPA and the synthetically produced L-allo and D-allo-HMPA. To
produce the allo acids, 5 mg each of L and D-isoleucine was solubilized in I ml 4N
HCI in separate vials. To each of these vials I ml of a 0°C solution ofNaNO2in
water (0.5 g/ml) was added and stirred at 0 °C for 4 hr and at room temperature
overnight. The solutions were then extracted repeatedly with diethyl ether, dried with
MgSO4and blown to near dryness with a stream ofN2gas. All standards and the
liberated residues of tortugun were methylated using diazomethane, followed by198
creation of the menthyl carbonates. As such, 0.2 mg of derivatized tortugin was
reacted with 20i.L1of menthyl carbonyl chloride (1.0 pmol/i1 (IR)-(-)-menthyl
carbonyl chloride in dry benzene) in 120 x1 dry benzene and 20 j.il dry pyridine for 2
hr at room temperature. The sample was dried under nitrogen and resuspended in
100% hexanes. GC/MS analysis followed using an initial temperature of 100 °C,
sustained for 0.5 mm and a thermal ramp of 3 °C/min to a final temperature of 240
°C. Tortugin coeluted with derivatized L-HMPA at tR20.60 mm (D-HMPA tR
20.95, D-allo-HMPA t 20.80, L-allo-}-IMPA t 20.37).
BRINE SHRIMPToXIcITYBIOASSAY
Evaluation for brine shrimp toxicity was performed as previously described
using Anemia sauna as the testorganism.104After a 24 hr hatching period, aliquots of a
10 mg/mL stock solution of 96 and 101 were added to test wells containing 5 mL of
artificial seawater and brine shrimp to achieve a range of final concentrations from
1.0-50 ppm. After 24 hr the live and dead shrimp were tallied.
ANTIMICROBIAL ASSAY
The antimicrobial activity of lyngbyabellin B was evaluated using standard
paper sensitivity disk-agar plate methodology (disk diameter, 6mm).127Lyngbyabellin
B showed a 10.5 mm zone of inhibition at 100 p.g and a slight halo at 10 j.ig against
Candida albicans (ATCC 14053). No activity was observed against Pseudomonas aeruginosa
(ATCC 10145), Escberichia co/i (ATCC 11775), Salmonella cho/eraesuis subsp. cho/eraesuis
(ATCC 14028), Bacillus subti/is (ATCC 6051), and Staphjilococcus aureus (ATCC 12600).199
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CHAPTER VT.
SUMMARY
To reiterate the "Thesis Statement" presented in Chapter I; Algaeare sessile
organisms often encountered in areas of intense species diversity andherbivory.171'
As such, many have developed methods of defense most suitable for their local
habitats. Chemical defense seems to be the defense of choice for smaller slow
growingalgae.17'9Since such secondary metabolites have been honed by evolutionary
forces to be biologically active compounds, they represent a downstream stage of the
"natural drug discovery process." The investigation of the secondary metabolites
present in natural systems has two valuable outcomes, 1) an enhanced understanding
and appreciation for the natural environment, with a heightened awareness of the
intricate processes that are present yet barely understood and 2) a contribution to the
drug discovery process by uncovering both biologically active and inactive secondary
metabolites produced by biosynthetic pathways that, while originally protecting more
prirmtive organisms, may lead to the next generation of pharmaceuticals which aid
humans.
Presented within this thesis are the results of an effort to explore the
secondary metabolites of marine algae. The overarching hypothesis of such work is
that marine algae produce metabolites, which can be isolated and chemically defined,
that will enhance the understanding of marine algae and their ecology and will play a
necessary 'front line' role in drug discovery efforts.202
The exploration of this hypothesis included the chemical investigation of
seven samples of marine algae, a red alga and six cyanobacterial extracts, and the
biological activity assessments of nearly 100 examples, representing all the major algal
divisions. In total, six compounds new to the literature have been isolated and
chemically defined as products of marine algae (Figure VLI). These secondary
metabolites were derived from algae originating from locations circling the globe,
including Fiji, Madagascar, Dry Tortugas (Florida), and Curacao.
A survey for toxicity against Biomp balaiia glabrata, was undertaken to examine
the molluscicidal activity present in marine algal extracts. It was posited that because
snails are a primary marine herbivore, marine algal extracts, if chemically defended
against molluscan predation, will display toxicity to freshwater molluscans as well.
Molluscicidal pursuits are stimulated in an attempt to control the spread of
schistosomiasis by eliminating the intermediate host (B. glabrata) of the causative
parasite, Schistosome mansoni. The marine algal extracts examined were found to be
strongly molluscicidal, with 46% displaying toxicity at 100 ppm and 34% of the
extracts active at 50 ppm. Notable activity was observed especially for members of
the Rhodophyta and cyanobactena. As such, the red alga Portiena hornemanni and two
Malagasy Lyigbja majuscula extracts were chemically investigated. Chondrocole C (60),
previously isolated as a feeding deterrent to fish, was isolated as the major
molluscicidal component of the dramatically active P.hornemanni.76The decreased
activity of the pure compound as compared to the more active fractions and crude
extract suggests either the susceptibility of 60 to degrade when in a pure state or the
synergistic activity of multiple compounds resulting in full toxicity. From twoBr1Bi
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Figure V1.1. Newly reported secondary metabolites from marine algaepresented
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different L majuscula extracts, the molluscicidal metabolites tanikolide(32)61and
debromoaplysiatoxin(20)63were isolated (Figure VT.2). Active at an LD0.003
ppm, debromoaplysiatoxin is one of the most potent molluscicides discovered.
Despite the activity of 20 as a PKC activator,TM such potency may have utility as a
molluscicide, especially in artificial waterways such as irrigation channels and rice
paddies. The overall frequency of activity observed for marine algal extracts against B.
glabrata, and the isolation of the active principle in three samples, supports the theory
that marine algae produce secondary metabolites that will be toxic to freshwater snails.
The discovery of chondrocole C as a molluscicidal secondary metabolite
inspired the further investigation of P. bomemanni. In total five polyhalogenated
monoterpenes were isolated, with one being the newly described taviochtodene. Also
isolated, in addition to 60, were chondrocole A/B(58,
59),752-chloro-1 ,6 (S), 8-
tribromo-3-(8)(Z)-ochtodene(44b),74and 2-dechiorohalomon
(55).73The last of these,
55,is a close structural relative of halomon(50),the promising anticancer lead that has
thus far remained naturally and syntheticallyelusive.72'73The small size and chemical
shift similarities within this structure class necessitate the extensive utilization of mass
spectrometry (especially GC/MS) and NMR experiments to accurately determine
chemical structures. Such experimentation led to the chemical shift re-assignment of
chondrocole C as compared to those made in the literature (FigureVI.3).76Also,
observations of the GC/MS fragmentation patterns for compounds containing
multiple bromine and chlorine atoms allowed for the empirical assessment of the
molecular weight of compounds, which lose halogens at ionization, and therefore
prior to detection (Figure VL4). The isolation of this suite of halogenatedo3
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monoterpenes from a Fijian P. hornemanni, suggests a new location to search for red
algal metabolites with therapeutic potential against cancer.
Despite lacking significant biological activity, the malyngarnides are an
intriguing and prominent Ljvngbya majuscula secondary metabolites structure class.
Malyngamides L (80), Q (70), and R (71), isolated from two different collections of L
majuscula, are some of the more recent literature additions for this growing structure
class. While malyngamide L shares many characteristics with the standardly
encountered cyclohexyl-type malynganiide, malyngamides Q and R offered some
intriguing differences. Firstly, they show structural similarity to malyngamides A (66)
and B (67), members of the less common pyrrolidone-type subclass of
malyngamides.8183Also, malyngamides Q and R were the first discovered
malyngamides with an alternative stereochemistry at the vinyl-halide carbon (Figure
'VT.5). The initial observation of this alternate stereochemistry by the ID DPFGSE
NOE pulse sequence helped lead to the development of the HSQMBC pulse
sequence by Dr. R. Thomas Williamson and Dr. Brian L. Marquez to confirm this
unique result by the accurate measurement of heteronuclear (H-C) coupling
constants.Following the publication of malyngamides Q and R, further examples of
malyngamides were discovered presenting this alternatestereochemistry.63'92Also, as a
result of the numerous malyngamide structures allowing the observation of molecular
trends, hypotheses have been developed which suggest that malyngamide biogenesis
proceeds through multiple acetate extensions of an amino acid, or amino acid derived,
starter unit, with eventual ring closure and structural tailoring (Figure VT.6).ppm
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From a Dry Tortugas sample of L majuscula two toxic cyclic depsipeptides,
lyngbyabeffinB (96)and tortugin (101), were isolated. LyngbyabellinB,toxic to brine
shrimp and Candida albicans, is a dichiorinated compound resembling the molluscan
derived dolabellin (108; Figure\Tl.7).116Tortugin, displaying activity against brine
shrimp, incorporates a seldom encountered terminal acetylene residue most commonly
observed in a series of molluscan secondary metabolites, but discovered in an
increasing number of cyanobacterial compounds (FigureVI.8).119The unambiguous
cyanobacterial derivation of96and 101 provide support for the theory that many
secondary metabolites attributed to molluscan de novo biosynthesis are originally
produced by microalgae. The secondary metabolites are subsequently passed up the
food chain through either direct or indirect predation. In some cases it appears that
the molluscan predator derives chemical protection from the cyanobacterial
metabolites through their accumulation and/or biotransformation.
Presented within this thesis are the results of an effort to explore the
secondary metabolites of marine algae which support the hypothesis that marine algae
produce metabolites which can be isolated and chemically defined and that will
enhance the understanding of marine algae. Furthermore, their products have the
potential to play a necessary 'front line' role in drug discovery efforts. Marine algae
provide the basis for studies that span a wide range of disciplines including natural
products chemistry, bioorganic chemistry, biochemistry, chemical ecology, classical
ecology, and aquatic botany, among many others. They also provide us with a window
into the intricately balanced undersea world, yielding, at once, tools with the potential214
to stem diseases which plague humans, and a greater understanding of the natural
environment.215
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